ENSPConference

on Tobacco Control:Research, Prevention

and Treatment.

5-7 April 2016, Brussels - Belgium

Under the auspices of two scientific journals:

http://tobaccoinduceddiseases.biomedcentral.com/ http://www.tobaccopreventioncessation.com/

- 2 -

- 3 -

Welcome to the ENSP Tobacco Control Conference

The European Network for Smoking and Tobacco Prevention (ENSP) has been active in tobacco control since 1997 and for the last 19 years has been playing an important role in setting and influencing policies at a European and in-ternational level. Spearheading ENSP activities and projects are national representatives, organisations, academics, doctors, lawyers, health care professionals, experts and activists who always worked together to fulfil the objectives and mission of ENSP.

ENSP is the only truly pan-European network active in tobacco control being the key grassroots organisation in im-plementing the World Health organization Framework Convention on Tobacco Control (WHO-FCTC) at a European level. This was acknowledged by the WHO-FCTC – Conference of Parties during the session in Uruguay (November 2010) when ENSP received FCTC observer status.

It is almost impossible to talk about FCTC in Europe without mentioning the involvement of at least one ENSP member. This united and collective effort is the essence, the heart and soul of the “Network” concept: each link makes the chain stronger; each node adds value to the structure. This added value is not only found in the strength of the partnership but also on a scientific level in everything ENSP does: its core activities, its EU projects but also its new scientific jour-nal, “Tobacco Prevention & Cessation”.

Tobacco consumption remains the single largest avoidable cause of premature death in Europe, responsible for 700,000 deaths every year, and is the most significant cause of health inequalities. It is an interesting time for our work in tobacco control, as the world recognises that the most effective policies are those based on scientific studies and solid evidence.

Therefore, this year the conference is dedicated to three main topics:Research – Research and science represent the base for lobby and advocacy activities. On 5th April, a special session is dedicated to the European research and Public Health Projects dealing with different tobacco control topics. In all those projects, ENSP is acting as a knowledge and networking hub, being a real support for researchers and partners involved in the projects’ implementation.Prevention – Next year ENSP celebrates 20 years of activities dedicated mainly to prevent tobacco consumption in Europe. During the conference, a series of workshops, plenary and parallel sessions aim to highlight its accomplish-ments based on constant guidance resulting from WHO FCTC and MPOWER strategies.Treatment – Wednesday April 6th is fully dedicated to the WHO-FCTC Art. 14’s implementation in Europe and we bring together, in a special training session, more than 50 experts from Armenia, Georgia, Romania, Russia and Ukraine, partner countries under the EPACTT Project developed in partnership with Global Bridges – Healthcare Alliance for Tobacco Dependence Treatment.

The above-mentioned topics demonstrate the diversity and complexity of our Network, which is dedicated to tobacco control in Europe. Furthermore, the International Society for the Prevention of Tobacco Induced Diseases has joined forces by sponsoring two symposiums on Thursday 7 April, reinforcing the importance of academic and scientific research in our work.

Bringing together more than 170 experts from over 30 countries, this Conference is a new step ahead in accompli-shing our two top priority objectives as stated in our Statute:• To have the WHO- Framework Convention on Tobacco Control implemented in Europe by 2020• To reduce the prevalence of tobacco use in Europe to below 5% by 2040.

During the conference, as you discover and meet special guests and speakers from the Academic and European Insti-tutions, World Health Organization, national authorities and well known non-governmental organisations involved in tobacco control at regional, national and international level, we hope you have the chance to share your expe-riences and insights pertaining to various facets of tobacco control.

On behalf of ENSP members and Secretariat, we are honoured to invite you to our Tobacco Control Conference in Brussels, the capital city of Belgium and Europe, and would like to thank you, as well as all the presenters, without whom this event would not be possible, for your work, your dedication and your loyalty.

ENSP Board and Secretariat

FoREWoRd

- 4 -

Under the auspices of two scientific journals:Tobacco Prevention & Cessation (ENSP) and Tobacco Induced diseases (ISPTId)

dAY 1: Tuesday 5th April 2016 (Tobacco Control Conference)

Session 1: The EU Tobacco Product directiveChairs: Francisco Rodriguez Lozano (Belgium), Cornel Radu-Loghin (Belgium)

09:00 - 9:10 Welcome & opening SpeechFrancisco Rodriguez Lozano, President ENSP - Belgium

09:10 - 9:35 Tobacco Products directive - new opportunities for EU tobacco controlAnna-Eva Ampelas - Belgium

09:35 - 10:00Calling on the European civil society to support global implementation of the WHo FCTC and its Protocol to Eliminate Illicit Trade in Tobacco ProductsVera Luiza da Costa e Silva - Switzerland

10:00 - 10:25 Science for tobacco control policiesConstantine Vardavas - Greece

10:25 - 10:45 Evaluating Tobacco Control Policies in 28 Countries (including 9 EU countries): The ITC ProjectGeoffrey T. Fong - Canada

10:45 - 11:00 Q&A - discussion

11:00 - 11:15 Coffee Break

Session 2: Policy and tobacco control Chairs: Brian Ward (Belgium), Pierre Bizel (Belgium)

11:15 - 11:35 Australian Tobacco Control AchievementsSimon Chapman - Australia

11:35 - 11:50Article 5.3 of the WHo Framework Tobacco Convention and the European om-budsman’s inquiry into tobacco lobbyingLambros Papadias - Belgium

11:50 - 12:10 Ingredients and additives in tobacco productsMartina Pötschke-Langer - Germany

12:10 - 12:30 Situation in France: a step forwardMichèle delaunay - France

12:30 - 12:45 Q&A - discussion

12:45 - 13:30 Lunch

Session 3: Tackling the Tobacco IndustryChairs: Niels Them Kjær (Denmark), Taru Kinnunen (USA)

Session 4: NGos in Tobacco Control PolicyChairs: Norma Cronin (Ireland); Takashi Hanioka (Japan)

13:30 - 13:50

Refuting tobacco industry researchPascal diethelm - Switzerland

The ERS role on Tobacco Control Policy in EuropeChristina Gratziou - Greece

13:50 - 14:10

does ‘Plain Packaging’ of Tobacco matter?Luke Clancy - Ireland

Citizen’s/Patients Role in Tobacco controlSusanna Palkonen - Belgium

14:10 - 14:30

Campaigning Against the Tobacco IndustryJoshua Abrams - USA

Romania - New Tobacco control law: an NGo perspectiveFlorin Mihălţan - Romania

14:30 - 14:45

Q&A - discussion Q&A - discussion

SCHEdULE

1

2

4

5

6

7

8

3

9

11

13

10

12

14

- 5 -

Session 5: Tobacco PreventionChairs: Krzysztof Przewozniak (Poland), Florin Mihaltan (Romania)

Session 6: Influence of research in Policy makingChairs: Roberta Savli (Belgium), Stephen Lequet (France)

14:45 - 15:05

Eurobarometer: an effective tool for tobacco pre-vention in EuropeNicolas Becuwe - Belgium

Implementing the FCTC: the challenge of monito-ring and accountabilityCompaore Nonguebzanga Maxime - Norway

15:05 - 15:25

Smoking prevention among youth: do we need educational programs?Lucia Maria Lotrean - Romania

The importance of using evidence-based e-health smoking cessation programsHein de Vries - Netherlands

15:25 - 15:45

Taxation and Illicit Trade Protocol, “Lethal weapons” against Tobacco IndustryStephen Lequet - France

The role of research in tobacco controlFilippos Filippidis - UK

15:45 - 16:00

Q&A - discussion Q&A - discussion

16:00 - 17:00 Walk to the European Parliament and security check

15

17

19

16

18

20

dAY 2: Wednesday 6th April 2016 (Smoking Cessation Training)

Session 7: European Research Projects(EU Parliament Room: PHS 5 B1)Chairs: Panagiotis Behrakis (Greece), Francisco Rodriguez Lozano (Spain)

17:00 - 17:10 Welcome from MEP

17:10 - 17:30 EQUIPT: supporting European stakeholders to make decisions about invest-ment in evidence-based tobacco control Silvia Evers and Hein de Vries - Netherlands

17:30 - 17:50 The TackSHS project - a collaborative H2020 projectEsteve Fernandez - Spain

17:50 - 18:10 ToB-G: Tobacco Cessation Guidelines for High risk PopulationsPanagiotis Behrakis - Greece

18:10 - 18:30 SILNE-R (Horizon2020)Anton Kunst - Netherlands

18:30 - 18:50EUREST PLUS - European Regulatory Science on Tobacco: Policy implementa-tion to reduce lung diseases - Proposal (Horizon2020)Constantine Vardavas - Belgium

18:50 - 19:00 Q&A Session

19:00 – 19:10 ENSP AwardsCornel Radu-Loghin - Belgium

19:10 - 19:15 Closing remarks from ENSP PresidentFrancisco Rodriguez Lozano - Belgium

19:30 - 21:30 Cocktail Reception

21

22

23

24

25

- 6 -

Session 8: Nicotine addiction and smoking cessationChairs: Constantine Vardavas (Greece), dominick Nguyen (Belgium)

09:00 - 9:30 Global Bridges: building an international network for tobacco dependence treatmentKatie Kemper - USA

09:30 - 9:55 Smoking Cessation in CoPd patientsCarlos Jimenez-Ruiz - Spain

9:55 - 10:15 A Brief tobacco intervention program in dental settings for developing countriesTakashi Hanioka - Japan

10:15 - 10:30 Q&A

10:30 - 10:45 Coffee Break

Session 9: Tobacco control and cessation in Eastern Europe - a situation analysisChairs: Cornel Radu-Loghin (Belgium), Katie Kemper (USA)

10:45 - 12:15

Smoking cessation services in ArmeniaArusyak Harutyunyan - Armenia

Tobacco control and cessation in Romania – a situation analysisAntigona Trofor - Romania

Tobacco control and cessation challenges in GeorgiaGeorge Bakhturidze - Georgia

Improve the quality of brief intervention skillsotto Stoyka - Ukraine

Tobacco control and cessation in Eastern Europe - a situation analysis: The Rus-sian PerspectiveAndrey demin - Russia

Tobacco control and cessation in Poland – a situation analysisKrzysztof Przewozniak - Poland

12:15 - 13:00 Lunch

Smoking Cessation workshopsFaculty: Taru Kinnunen, Vicky Katsaounou, Tasos Fotiou, Victoria Vivilaki, Antigona Trofor

13:00 - 13:30

Workshop 1: organizing a Cessation Clinic• 5As delivery and evidence-based tobacco treatment and best practices in clinical settings• Organizing a smoking cessation clinic• Practice tools (Tobacco Use Survey, Smoking Consult Form, and Quit Plan) and protocols for smoking cessation in your practice setting

13:30 - 14:30Workshop 2: Counselling Techniques: Patients Ready to Quit• How to implement effective techniques for preparing for a quit attempt within a brief clinic visit and addressing common barriers (e.g. cravings, withdrawal, caffeine) to successful quitting

dAY 2: Wednesday 6th April 2016 (Smoking Cessation Training)

26

27

28

29

14:30 - 15:15

Workshop 3: Counselling Techniques: Patients Not Ready to Quit (Moti-vational Interviewing)• How to implement effective techniques for motivating smokers and preparing for a quit attempt within a brief clinic visit and addressing common barriers (e.g. motivation, weight gain)• Motivational Interviewing techniques will be emphasized

15:15- 15:30 Coffee Break

15:30- 16:15

Workshop 4: Results of the TOB-G project (Public Health Programme): development of tobacco treatment guidelines for high risk groups• Smoking cessation in smokers with medical co-morbidities• Smoking Cessation in Adolescents• Smoking Cessation for Pregnant and Breastfeeding Mothers

16:15- 16:45Workshop 5: Smoking Cessation PharmacotherapiesOverview of first-line smoking cessation pharmacotherapies and their use in helping patients quit smoking

16:45- 17:30Workshop 6: How to assess smoking abstinence using Co measurementsHands on training on how to use CO monitors to evaluate smokers abstinence and the effectiveness of smoking cessation

17:30 – 17:45 EPACTT FacultyClosing remarks and smoking cessation workshop programme evaluation

day 3: Thursday 7th April (Tobacco Induced diseases sponsored symposiums)

- 7 -

day 3: Thursday 7th April (Tobacco Induced diseases sponsored symposiums)

Session 10: Tobacco Induced diseases Sponsored Symposium 1 Chairs: david Scott (USA), J. Elliott Scott (Canada)

09:00 - 9:20 Welcoming Remarks and ISPTId:Constantine Vardavas - Greece, Elliot Scott - Canada

09:20 - 9:40 Women and smoking: Global challengeTaru Kinunnen - USA

10:00 - 10:20Caspase 3 activity in isolated fetal rat lung fibroblasts and rat periodontal liga-ment fibroblasts: cigarette smoke-induced alterationsJ. Elliott Scott - Canada

10:20 - 10:40 Cigarette smoking and bacterial infectiondavid Scott - USA

10:40 - 11:00differentiation of chronic and aggressive forms of periodontitis and of smokers and non-smokers by Fourier-transform infrared spectroscopyNurcan Buduneli - Turkey

11:00 - 11:15 Lung cancer and smoking among women – a new challenge in EuropeWitold Zatonski - Poland

11:15 - 11:30 Coffee break

Session 11: Tobacco Induced diseases Sponsored Symposium 2: Tobacco Use and Cessation Challenges and Solutions Chairs: Witold Zatonski (Poland), Taru Kinunnen (USA)

11:30 - 11:45Cytisine in the treatment of tobacco dependence: safety, efficacy, market in Eas-tern EuropeAleksandra Herbeć - Poland

11:30 - 11:45Availability, Affordability, and Prices of Smoking Cessation Products in 9 Coun-tries: Preliminary FindingsArusyak Harutyunyan - Armenia

12:00 - 12:15TITAN Crete (Tobacco Treatment Training Network in Crete). designing Smoking Cessation intervention in Primary Care Practice: Preliminary dataCharis Girvalaki - Greece

12:15 - 12:30 Helping people stop smoking in workplaces: an alternative pathJoseph osman - France

12:30 - 12:45 The Hookah: Not Benign and Not CulturalBarry Finegan - Canada

12:45 - 13:00 Tobaccofree Sports Stadia: European Policies and GuidanceMatthew Philpott - UK

13:00 - 13:15 Closing remarks ISPTIdConstantine Vardavas - Greece & J. Elliott Scott - Canada

13:15 - 14:30 Lunch

30

31

32

33

34

35

36

37

38

39

40

• European Accreditation Council for Continuing M

edical Education • European Accreditation Council

for C

ontin

uing

Med

ical E

duca

tion

The European Network for Smoking and Tobacco Prevention (ENSP) / EPACTT- Treating Tobacco De-pendence Programme has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS)

- 8 -

France

French Alliance Against Tobacco

DNF - Les Droits des Non-Fumeurs

Portugal

PortugueseConfederation

for SmokingPrevention

Hungarian Alliancefor Tobacco Control

Spain

Comité Nacionalde Prevención

del Tabaquismo (CNPT)

Italy

Società Italianadi Tabaccologia

Ireland

ASH Ireland

Tobacco-Free Research Institute

United Kingdom

Tobacco Free Futures

Belgium

Prevention Tabac Wallonie

Netherlands

Partnership Stopmet Roken

Luxembourg

Fondation Cancer

Denmark

Danish Coalition Against Tobacco

Danish Health and Medicines Authority

Danish Cancer Society Germany

German Medical Action GroupSmoking or Health

Poland

Health PromotionFoundation

Smart Health Foundation

The Main Councilof Nurses and Midwives

Greece

Greek CoalitionAgainst Tobacco

Institute of Public Healthof the American College of Greece

Laboratory of Toxicology,Faculty of Medicine, University of Crete

Hellenic Thoracic Society

Estonia

NGO Tobacco-free

Regional AdvocacyCentre Life

Cyprus

Cyprus National Coalition for Smoking Prevention

Turqey

Turkish Respiratory Society

Lithuania

Lithuanian National Tobaccoand Alcohol Control Coalition

Georgia

Tobacco ControlAlliance in Georgia

Austria

Austrian Councilon Smoking and Health

Slovenia

Slovenian Coalitionfor Tobacco Control

Romania

Romanian Network for Smoking Prevention

Aer Pur Romania

Romanian Prevention Forum

United Youth Association

Moldova

Centre for Health Policiesand Studies (PAS Centre)

Bulgaria

Ukraine

Bulgarian Anti-Tobacco Coalition

Smoke Free Life Coalition

Bulgaria Youth Prevention Foundation

Swiss Associationfor Smoking Prevention

Hungary

Switzerland

Sweden

TeachersAgainstTobacco

ENSP FULL & ASSOCIATED MEMBERS

- 9 -

France

French Alliance Against Tobacco

DNF - Les Droits des Non-Fumeurs

Portugal

PortugueseConfederation

for SmokingPrevention

Hungarian Alliancefor Tobacco Control

Spain

Comité Nacionalde Prevención

del Tabaquismo (CNPT)

Italy

Società Italianadi Tabaccologia

Ireland

ASH Ireland

Tobacco-Free Research Institute

United Kingdom

Tobacco Free Futures

Belgium

Prevention Tabac Wallonie

Netherlands

Partnership Stopmet Roken

Luxembourg

Fondation Cancer

Denmark

Danish Coalition Against Tobacco

Danish Health and Medicines Authority

Danish Cancer Society Germany

German Medical Action GroupSmoking or Health

Poland

Health PromotionFoundation

Smart Health Foundation

The Main Councilof Nurses and Midwives

Greece

Greek CoalitionAgainst Tobacco

Institute of Public Healthof the American College of Greece

Laboratory of Toxicology,Faculty of Medicine, University of Crete

Hellenic Thoracic Society

Estonia

NGO Tobacco-free

Regional AdvocacyCentre Life

Cyprus

Cyprus National Coalition for Smoking Prevention

Turqey

Turkish Respiratory Society

Lithuania

Lithuanian National Tobaccoand Alcohol Control Coalition

Georgia

Tobacco ControlAlliance in Georgia

Austria

Austrian Councilon Smoking and Health

Slovenia

Slovenian Coalitionfor Tobacco Control

Romania

Romanian Network for Smoking Prevention

Aer Pur Romania

Romanian Prevention Forum

United Youth Association

Moldova

Centre for Health Policiesand Studies (PAS Centre)

Bulgaria

Ukraine

Bulgarian Anti-Tobacco Coalition

Smoke Free Life Coalition

Bulgaria Youth Prevention Foundation

Swiss Associationfor Smoking Prevention

Hungary

Switzerland

Sweden

TeachersAgainstTobacco

ENSP FULL & ASSOCIATED MEMBERS

- 10 -

Abstract 2 - 09:35 - 10:00

dr Vera Luiza da Costa e SilvaHead of Convention Secretariat, Convention Secretariat, WHo FCTC - SwitzerlandCalling on the European civil society to support global implementation of the WHo FCTC and its Proto-col to Eliminate Illicit Trade in Tobacco Products

BIoGRAPHIES & ABSTRACTSAbstract 1 - 9:10 - 9:35

dr Anna-Eva AmpelasActing Head of Unit, dG Sante Unit B2 - BelgiumTobacco Products directive - new opportunities for EU tobacco control

Abstract 3

Abstract:The Tobacco Products Directive 2014/40/EU was adopted in 2014 and needs to be transposed by Member States by 20 May 2016.It sets out ambitious tobacco control measures in the areas of ingredients, packaging & labelling, electronic cigarettes and tracking & tracing. The new Directive focuses on pre-venting young people from taking up smoking.

Abstract:The intervention of the Head of the Convention Secretariat will focus on how the European civil society could support global implementation of the WHO FCTC and its Protocol to Eliminate Illicit Trade in Tobacco Products. The Convention celebrated its 10 years of existence last February and cur-rently has 180 Parties that committed themselves towards implementing its requirements. Almost all European states and the European Union have ratified the Convention and working on its implementation. The intervention will focus on the roles the European civil society could play to stren-gthen its contribution, at national, sub-regional and global levels, in implementation of the Convention. The Protocol to Eliminate Illicit Trade in Tobacco Products, a new inter-national treaty, that will open new avenues for collabora-tion between the various sectors, is still to enter into force. Its implementation will also need support from the side of the civil society.Biography:Dr da Costa e Silva is medical doctor, with a PhD in Public Health and Epidemiology and a Masters in Business Admi-nistration for the Health Sector. For 16 years she coordi-nated the department of epidemiology and cancer preven-tion at Brazil’s National Cancer Institute and was involved

Biography:Anna-Eva Ampelas is the Acting Head of Unit in DG Sante, Unit B2 Health in All Policies, Global Health and Tobacco Control in the European Commission. She has more than ten years experience of working on tobacco control from a EU and global perspective (WHO FCTC). Before joining the Commission in 2006, Anna-Eva was Health Counsellor at the Permanent Representation of Sweden. Anna-Eva has a Master of Laws from Uppsala University.

in legislative, economic, surveillance and regulatory tobac-co-control measures, the establishment of a country-wide tobacco control network and the introduction of tobacco products as part of the recently established health regula-tory agency. From 2001 to 2005, she was Director of the Tobacco Free Initiative at WHO in Geneva, among other things supervising the work of the Interim Secretariat of the WHO FCTC.Since 2006 she has worked as a senior public health consul-tant to WHO, providing advice to the Tobacco Free Initia-tive and WHO’s Department for the Prevention of Noncom-municable Diseases as well as the Secretariat of the WHO FCTC. She also worked as consultant to the Government of Brazil and supported the preparation of Brazil’s 2011–2022 Action Plan on NCDs.In addition, in 2007 she worked as Team Leader of To-bacco Control and Consumers’ Health at the Pan Ameri-can Health Organization in Washington, DC. In 2013 she was the founder and the first Coordinator of the Centre for Studies on Tobacco and Health, within the National Public Health School of the Oswaldo Cruz Foundation, Brazil. Since the end of June 2014, Dr da Costa e Silva has been the Head of the Secretariat of the WHO FCTC.

- 11 -

Abstract 4 - 10:25 - 10:45

Prof. Geoffrey T. FongProfessor of Psychology and Public Health and Health Systems, University of Waterloo - CanadaEvaluating Tobacco Control Policies in 28 Countries (including 9 EU countries): The ITC Project

Abstract 3 - 10:00 - 10:25

dr Constantine Vardavas, Md, RN, MPH, Phd, FCCPAssociated director, Institute of Public Health of the American College of Greece - GreeceScience for tobacco control policies

Abstract 5 - 11:15 - 11:35

Prof. Simon ChapmanEmeritus Professor, University of Sydney - AustraliaAustralian Tobacco Control Achievements

Abstract 6

Abstract:The recent adoption of the Tobacco Products Directive is a unique opportunity to enhance the regulation of tobacco products in the European Union. In this presentation a brief overview of the development of a EU common reporting format for submission of data on ingredients contained in tobacco and related products will be presented, as an exa-mple of European tobacco regulatory science.

Abstract:Since its start in 2002, the ITC Project has been conduc-ting evaluation studies of tobacco control policies via pros-pective cohort surveys of tobacco users in 28 countries, including 9 EU countries. This presentation will focus on the design of the ITC Project and how it differs from and complements existing evidence-gathering systems (mo-nitoring and surveillance systems) in measuring and un-derstanding the impact of FCTC policies. The presentation will also describe the ITC Project’s most recent initiatives: (1) the EUREST-PLUS study focusing on measuring the impact of the Tobacco Products Directive, and (2) a large-

Abstract:With the historic implementation of plain tobacco packa-ging in December 2012, Australia has arguably the most comprehensive system of tobacco control policy and prac-tice of any nation. Daily smoking prevalence in those aged 14+ was 12.8% (in 2013) with the next data set due later this year. Australia vies with Canada to have the lowest smoking prevalence of any nation. This presentation will outline the leading factors contributing to the decline, em-phasising the population rather than individual/clinical focus of policies and programs; the interrelationship of distal and proximal factors in understanding the dynamics of the decline; and the vital role of media advocacy over decades that has conditioned public and political aware-ness and values, essential for fomenting policy change.

Biography:Dr Vardavas is a recognised international expert on tobac-co control, with a specific focus on European tobacco re-gulatory science. A former Senior Research Scientist at the Center for Tobacco Control at the Harvard School of Public Health, he is now based in Europe and spearheads a subs-tantial number of European-wide initiatives and projects to advance the science behind tobacco control and support the impact of the Tobacco Products Directive. He is the co-Editor-in-chief of the ISPTID journal, Tobacco Induced Di-seases.

scale international cohort study of e-cigarettes starting in the United States, Canada, England, and Australia.Biography:Professor Fong is the Founder and Chief Principal Investi-gator of the International Tobacco Control Policy Evalua-tion Project (the ITC Project), the first-ever international cohort study of tobacco use, whose primary objective is to evaluate and understand the impact of tobacco control po-licies of the WHO FCTC. The ITC Project is being conducted in 28 countries, inhabited by over 50% of the world’s popu-lation, 60% of the world’s smokers, and 70% of the world’s tobacco users.

Biography:Simon Chapman AO is Emeritus Professor in Public Health at the University of Sydney. He has published over 500 ar-ticles, editorials and commentaries in peer reviewed jour-nals and 19 books and major reports. In 2003 he was voted by his international peers to be awarded the American Cancer Society’s Luther Terry Award for outstanding in-dividual leadership in tobacco control. In 2008 he won the NSW Premier’s Cancer Researcher of the Year medal. In 2013 he was made an Officer in the Order of Australia for his contributions to public health and named 2013 Austra-lian Skeptic of the Year. In 2014, the Australian right wing think tank, the Institute of Public Affairs, named him as one of Australia’s Dirty Dozen all-time “opponents of freedom”.

- 12 -

Abstract 7 - 11:50 - 12:10

dr Martina Pötschke-LangerHead of the Unit Cancer Prevention, German Cancer Research Center - GermanyIngredients and additives in tobacco products

Abstract 6 - 11:35 - 11:50

Mr Lambros PapadiasHead of Unit, Complaints and Inquiries, European ombudsman - BelgiumArticle 5.3 of the WHo Framework Tobacco Convention and the European ombudsman’s inquiry into tobacco lobbying

Abstract 8

Abstract:The Ombudsman investigates complaints about malad-ministration in the EU institutions, agencies and bodies. A complaint was brought by an NGO which claimed the Commission was not meeting its obligations under the WHO’s Framework Convention on Tobacco Control. The Ombudsman agreed, finding that the Commission’s ap-proach to publicising meetings with tobacco lobbyists was, with the exception of DG Health, inadequate, unreliable and unsatisfactory. The Ombudsman was also concerned to find that certain meetings with lawyers representing the tobacco industry were not considered as meetings for the purpose of lobbying.Biography:Lambros Papadias is a lawyer (Athens Bar), specialised in European law. He started his career with the law firm of Freshfieldsfirm in Brussels, and then served as a “Référen-daire” at the General Court of the EU in Luxembourg where he clerked for Judge A. Kalogeropoulos (1994-1998) and

Abstract:Tobacco smoke contains numerous toxic and carcinoge-nic substances. Some are naturally present, but many are added during manufacturing or are formed during com-bustion of the product. Additives are added mainly to in-fluence the tobacco taste or for moisturizing and burning characteristics.They include any colouring agents, adhe-sives, plasticizers, binders, etc. that are included in the fil-ter, the paper and in tobacco.More than 600 different ad-ditives are known, these can account for about 10 up to 25 percent of the total weight of a cigarette. Additives trans-form tobacco smoke into an even more complex chemical mixture and further increase the carcinogenic and harmful effects of smoking. The presentation will demonstrate how additives are used to facilitate smoking and contribute to

Judge M. Vilaras (1998-2000), dealing mainly with an-titrust and State aid actions for annulment. In April 2000 he joined the Antitrust Telecoms unit of DG Competition (European Commission) dealing. During that period he drafted the “Commission Guidelines on market definition and SMP”, the Commission Telecoms “Liberalisation Direc-tive”, and the Commission Recommendation on “Article 7 Notifications under the Telecoms Framework Directive”. In 2005, he joined DG COMP’s State Aid unit where he dealt with Broadband Policy issues, and drafted the «Commu-nity Guidelines for the application of State aid rules in relation to rapid deployment of broadband networks in the telecoms sector» (2009). In 2009, he was appointed Deputy Head of Unit, responsible for DG COMP’s Fiscal Team dealing with State aid fiscal issues. Since September 2012, he is the Head of Complaints and Inquiries Unit III, at the European Ombudsman Office. He has published and spoken regularly on EU issues related to antitrust law, te-lecommunications, and EU litigation matters.

increased addictiveness and how flavoring agents can in-crease the attractiveness of tobacco products.Biography:Martina Pötschke-Langer is Medical Doctor and Master of Science in German literature and German history. She was educated at the University of Heidelberg. Since 1997 she is Head of the Unit of Cancer Prevention in the German Cancer Research Center with special focus on tobacco pre-vention and tobacco control research in Germany. In 2002 the Unit Cancer Prevention was designated as WHO Col-laborating Centre for Tobacco Control. Since 2000 she is editor of the “Red Series Tobacco Prevention and Control” and further publication series of the German Cancer Re-search Center. Also numerous peer-reviewed articles were published.

- 13 -

Abstract 9 - 13:30 - 13:50

Mr Pascal diethelmPresident, oxyRomandie - SwitzerlandRefuting tobacco industry research on plain packaging

Abstract 8 - 12:10 - 12:30

Mrs Michèle delaunayMember of Parliament, French Parliament - FranceSituation in France: a step forward

Abstract 10

Abstract:The presentation will look at four key issues: The new to-bacco control provisions in French Health Law (January 2016), including plain packaging and health warnings; obligation for the tobacconists to control the age of buyers, to make effective the prohibition to sales to minors; prohi-bition of smoking in a car with a child under 18 years; in-creasing the share reimbursed by French Social Security system for nicotine replacement therapies; prohibition of tobacco advertising in tobacconists shops. The weaknesses in the law and the priorities of the French Coalition against tobacco, such as the increase tobacco taxes and prices; class action for the tobacco victims; Tobacco Prevention Fund; Ensure enforcement of the law Tobacco lobbying in France: French tobacconists ; Ministry of Economy; the to-bacco industry… Tackling tobacco: a pre-requisite to save

the sustainability of our health system (health and social costs).Biography:- Hospital Doctor, specialised in oncology, hematology, ra-diotherapy dermatology. Head of Unit of onco-dermatolo-gy CHU de Bordeaux (1981-2012) . - Member of the Gironde (Bordeaux) since 2007, member of the Social Affairs Committee , Vice President of the So-cialist Group (age policy). - Member of the French Parliament responsible for Seniors and autonomy (2012-2014). - Rapporteur of the 2016 Social Security Budget.- Since December 2015, President of «Alliance Contre le Ta-bac», an alliance of thirty organisations involved in health.

Abstract:In its response to the UK government consultation on plain packaging in 2014, Philip Morris International claimed that the introduction of the measure in Australia had no effect whatsoever. The company invoked studies conducted by two professors at the University of Zürich, claiming that “the experts found no evidence that ‘standardised packa-ging’ had had an effect on smoking prevalence among Aus-tralians,” adding that the professors “confirmed that if there had been an effect in reality … it would have been reflected in the data.” The two studies, which were published on the UZH website as “working papers” have been criticized for their methodological defects. In a recent paper, published in Tobacco Prevention and Cessation, Diethelm and Farley re-analysed the data used by the two professors, and ar-rived at results, which refuted their findings. They found that a significant decline in smoking prevalence in Austra-lia followed the introduction of plain packaging after ad-justment for the impact of other tobacco control measures. The effect was even stronger than what the experts had predicted. What causes particular concern in the present case is the attitude of the University of Zürich: it opted for the «ostrich policy», hiding behind «academic freedom» to avoid assuming its responsibility when confronted with a

clear attempt by the tobacco multinational to use the aca-demic institution for manufacturing «science» favourable to its commercial interests.Biography:Pascal Diethelm spent most of his professional career wor-king at the World Health Organization. Since his retire-ment, he has taken an active role in tobacco control, both at the national level and internationally. In 2001, he revealed, with Dr Jean-Charles Rielle, that a reputed professor who led the departments of environmental health at the Univer-sity of Geneva had been secretly working for Philip Morris for 30 years, conducting studies denying the toxicity of se-cond-hand smoke, revelation which was confirmed by the Swiss courts in a now famous libel case known as the “Ry-lander affair”. Pascal Diethelm has also studied, together with prof. Martin Mckee, the phenomenon of denialism. Pascal Diethelm is president of OxyRomandie, a Swiss NGO dedicated to tobacco control. He is vice-president of French NGO Comité National Contre le Tabagisme and board member of CIPRET-Genève, the Geneva Centre for Information on Smoking Prevention. He is a founding member of the Framework Convention Alliance (FCA).

- 14 -

Abstract 11 - 13:50 - 14:10

Prof. Luke Clancydirector General TobaccoFree Research Institute - Irelanddoes ‘Plain Packaging’ of Tobacco matter?

Abstract 12

Abstract 10 - 13:30 - 13:50

Prof. Christina GratziouProfessor of Pulmonary Medicine , Athens University - GreeceThe ERS role on Tobacco Control Policy in Europe

Abstract:The European Respiratory Society is an international medi-cal organisation that brings together physicians, healthcare professionals, scientists and other experts working in respi-ratory medicine. Its aim is to alleviate suffering from respi-ratory diseases and promote lung health globally through science, education and advocacy. ERS has since its foun-ding in 1990 demonstrated strong commitment to tobacco control . Through scientific assemblies, education courses, various alliances and collaboration (Framework Conven-tion Alliance, European Chronic Disease Alliance, World Health Organisation etc.) As well as a Tobacco Control Com-mittee (TCC) dedicated to advocacy, ERS constantly strives to promote strong and evidence-based policies to reduce the burden of tobacco related diseases. One of the main outco-me of the TCC is the creation of Smokehaz, a website aimed at providing policy-makers with scientific information on the Health hazards associated with smoking. Recently, ERS created the Latin-America Working Group which aims at strengthening tobacco control activities in Spain, Portugal and Latin-American countries.

Biography:Chair of Advocacy Council of ERS Professor of Pulmonary and Critical Care Medicine, Medical School of Athens Uni-versity Head of University Respiratory Unit, Asthma and Allergy Center-Head of Smoking Cessation Clinic in Pul-monary and Critical Care Department Medical School, in the University of Athens.Clinical and research work focus on asthma, respiratory allergy, chronic obstructive diseases, smoking cessation, to-bacco control policies. Reviewer of International Journals. Scientific participation in more than 100 international mee-tings with over 250 active presentations and many (>120) publications with a great IF and a high number of citations, on clinical and basic research on topics like airways inflam-mation on asthma, COPD and smoking cessation strategies and therapeutic approaches.

Abstract:The incremental tightening of the tobacco industry’s adver-tising capabilities led to the investment of billions of dol-lars into increasingly creative packaging. Today, packing remains one of the industry’s sole methods of promotion and marketing. The size, shape, colour, and font on ciga-rette packs serve to differentiate brands and promote a certain image associated with the given cigarette package Many studies in recent years have tested the association between pack standardisation and peoples’ attitudes, be-haviours, and perceptions of tobacco packaging.The re-sults show that plain packs are thought to be less attractive and associated with less positive characteristics, the health warnings are more salient, and smokers report feelings of wanting to smoke less when using standardised packs. Now we have the real life results from Australia which show the tobacco control advances that are possible with standardised packaging.This must increase the pressure to have ‘plain packaging’ introduced throughout the EU.

Biography:Professor Luke Clancy, BSc, MB, MD, FRCPI, FRCP (Edin), FFOMRCPI, PhD (DIT) Director General, TobaccoFree Research Institute Ireland (TFRI) Dublin. Consultant Res-piratory Physician Luke Clancy is an academic physician with a track record in the area of smoking and health and in respiratory diseases particularly air pollution, asthma, cancer and tuberculosis. He has directed and co-ordinated many national and international research projects on these conditions. His current research focus is on the prevention of smoking related diseases. As Chairman of the Board of ASH Ireland (Action on Smoking and Health) he led the Health Alliance which played a significant role in achieving Smokefree legislation in Ireland. He is a Past President of ENSP and of Euro Region of IUATLD www.tri.ie

- 15 -

Abstract 12 - 13:50 - 14:10

Ms Susanna Palkonendirector, EFA European Federation of Allergy and Airways diseases Patients’ Associations - BelgiumCitizen’s/Patients Role in Tobacco control

Abstract 14 - 14:10 - 14:30

Prof. Florin MihălţanPresident of the Romanian Network for Smoking Prevention Institut of Pneumology”M.Nasta” - RomaniaRomania - New Tobacco control law: an NGo perspective

Abstract 15

Abstract 13 - 14:10 - 14:30

Mr Joshua AbramsRegional director, Eurasia Campaign for Tobacco-Free Kids - USACampaigning Against the Tobacco Industry

Abstract:Health NGOs and patient groups representing people whose diseases are caused, exacerbated or worsened by smoking or exposure to tobacco smoke have key role to play in tobac-co control and advocacy, as well as a responsibility to do so. Their participation, advocacy and educational activities, such as patient education, peer support and help-line pro-grammes are based on evidence on the impact of tobacco use. They bring the citizen’s and patients’ perspective, hu-man face and impact on everyday life that tobacco conti-nues to have in our societies. EFA, European Federation of Allergy and Airways Diseases Patients Associations and its national members take European responsibility in inserting patient perspective in tobacco control at European and na-tional levels, in synergy with the health NGO coalition.

Biography:Susanna Palkonen is Director of European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), which brings together 39 member associations from 24 countries to improve the care, environment, participation and equality of people with allergy, asthma and COPD at the European level, including tobacco prevention. As Vice President of the European Patients’ Forum EPF, the umbrel-la association for 64 European level disease specific patient groups and national platforms of patient associations she is a member European Medicines Agency (EMA) Patient and Consumer Working Party. She is also the patient represen-tative in the Horizon 2020 Scientific Panel for Health.

Abstract:The Campaign for Tobacco-Free Kids and our partners have conducted a number of campaigns to expose and dis-credit tobacco industry interference in public policy ma-king. The presentation will look at case studies of some of these campaigns and show how this kind of work can help defeat tobacco industry opposition to strong tobacco control laws.Biography:Joshua Abrams is Regional Director for Eurasia Programs at the Campaign for Tobacco-Free Kids. In this role he has

Abstract:In our presentation we are evaluating the progress of the tobacco control in Romania looking form the point of view on NGO in the last 26 years. We are signalling the progressive steps towards policy and an advocacy from our perspective and the consequences of our success. The final result is reflected in the new law starting in force on March 17th, 2016, a real advance in our fight. We are iden-tifying in the same time the new challenging problems after launching the new law. Probably the biggest gain of our fight is the extensive partnership with all the factors ,our efforts to bring together in a big family as the coalition “Ro-mania Respira” politicians, advocates, judges, economists, young’s and also the new way found to encourage all: mass media, politicians, journalists, public to support us.

worked with partners to facilitate the enactment, passage, and enforcement of important public health legislation throughout East Europe and the former Soviet Union. Mr. Abrams’ experience in the region spans 20 years, during which time he has lived in or visited nearly all the former soviet states and worked for a variety of international aid organizations. He received MPA/MA from Indiana Univer-sity in 2002 and BA from Bard College. Mr Abrams was a Peace Corps volunteer in Kazakhstan and studied Russian in St Petersburg, Russia. He has also written on political and environmental issues in Eurasia.

Biography:Author of over 500 papers published in Romanian Revue and Romanian journals, as well as 20 papers published in Revue de Maladie Respiratoire, Pneumologie, Chest etc., Prof Florin Mihaltan is interested and involved in studies about quitting smoking, home assistance of patients with chronic obstructive pulmonary disease, and in somnology. Author of many inquiries about smoking in Romania and studies on tobacco control, prevalence of smoking in Ro-mania, he has many roles including President of the Ro-manian Society of Pneumology, Vice-president of the asso-ciation»Aer Pur» and President of the Romanian Network for Smoking Prevention. He has been a Board member for ENSP since April 2015.

- 16 -

Abstract 17 - 15:05 - 15:25

dr Lucia Maria Lotrean, Md, PhdLecturer, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca - RomaniaSmoking prevention among youth: do we need educational programs?

Abstract 18

Abstract 16 - 14:45 - 15:05

Mr Compaore Nonguebzanga MaximeSpecial Adviser, International Affairs Norwegian Cancer Society/ Framework Convention Alliance - NorwayImplementing the FCTC: the challenge of monitoring and accountability

Abstract:Parties to the WHO Framework Convention on Tobacco Control (FCTC) are legally bound by its provisions and are already obliged to provide detailed reports every two years on FCTC implementation. However, to date, the practical and political consequences of failure to comply are small. What is needed now is an organised system to review and follow up on the reports – an effective compliance mecha-nism – as has been created for many other treaties at about this stage in their development. In 2016, the Framework Convention Alliance (FCA) will advocate for the establi-shment of an effective FCTC compliance mechanism at the seventh session of the FCTC Conference of the Parties (COP7). The Alliance will also engage in discussions on the

Abstract:This presentation focuses on smoking prevention among adolescents and young people. Highlights include conside-rations regarding school-based programmes, family based interventions, community programs, mass-media cam-paigns and the use of new forms of information and com-munication technology for smoking prevention and health promotion. It will address issues regarding development, implementation, evaluation and diffusion of smoking pre-vention programs for youth and will explore the role of educational programs within tobacco control long-term strategies.

most meaningful and supportive role of civil society as part of this mechanism.Biography:Nonguebzanga Maxime Compaoré is a Special Adviser for International Affairs at the Norwegian Cancer Society (NCS), the largest cancer control civil society organisation in Norway that contributes to targeted efforts in cancer information, prevention, advocacy, research, care, and international cooperation. He is a Board member repre-senting organisations of the WHO European Region and Chair of the Board of Directors of the Framework Conven-tion Alliance for Tobacco Control (FCA), the voice of civil society for global tobacco control. The FCA is an alliance of nearly 500 organisations from over 100 countries.

Biography:Lucia Maria Lotrean is a medical doctor working at the Department of Community Medicine from Iuliu Hatie-ganu University of Medicine and Pharmacy, Cluj-Napo-ca, Romania. She is also a member of the NGO Pure Air, Romania. Dr Lotrean has performed her PhD thesis at Maastricht University, the subject of the thesis being Ro-manian adolescents: health risk behaviours and smoking prevention. She has experience in development, implemen-tation and evaluation of health promotion programs for youth, one main area of interest being smoking prevention.

Abstract 15 - 14:45 - 15:05

Mr Nicolas BecuweSenior director, TNS opinion - BelgiumEurobarometer: an effective tool for tobacco prevention in Europe

Abstract:The presentation will highlight the key results of the latest Eurobarometer survey about «Attitudes of Europeans towards tobacco and electronic cigarettes” which explores behaviours and attitudes of Europeans towards tobacco. This survey was conducted among more than 27,000 res-pondents aged 15 or more in the 28 Member States of the European Union in December 2014. The main topic will be prevalence of smoking in Europe, issues related to starting and stopping smoking, factors that influence the choice of cigarettes or e-cigarettes, exposure to tobacco smoke and advertisement and attitudes to tobacco and e-cigarette control policies.

Biography:Nicolas is a senior director with over 10 years of expe-rience in public affairs research. He advises and works clo-sely with a range of international clients (institutions and organisations) on political and social research projects. He is responsible for the management of Eurobarometer surveys on the account of the European Commission and the European Parliament. Over the last five years, he has worked closely with DG SANTE (European Commission) on surveying attitudes and behaviours towards tobacco in Europe.

- 17 -

Abstract 18 - 15:05 - 15:25

Prof. Hein de VriesProfessor in Health Communication, Maastricht University - NetherlandsThe importance of using evidence-based e-health smoking cessation programs

Abstract 20 - 15:25 - 15:45

dr Filippos FilippidisLecturer in Public Health, Imperial College London - United KingdomThe role of research in tobacco control

Abstract 21

Abstract:eHealth programs have become very popular to help people to quit smoking. Yet, the efficacy of eHealth programs is dependent on the health communication theories used and applied in these programs. Computer tailored technolo-gy has shown to be an effective tool to help people to quit smoking. Programs with even one session can increase the success rates significantly. During this presentation I will discuss several computer tailored eHealth programs for smoking cessation that have been developed and tested at Maastricht University. I will discuss the theoretical groun-ding of these programs, their effects and the cost-effective-ness. Additionally I will also outline some potential innova-tions for eHealth programs, and will also share the results

of a test comparing eHealth and mHealth.Biography:Hein de Vries is involved in multiple research projects testing the efficacy of smoking cessation interventions, including computer tailored eHealth and evidence based smoking cessation guidelines which are now incorporated in the Dutch standard for GP’s. He is collaborating in seve-ral international projects and has been a visiting professor for the University of KwaZuluNatal, Metz University and currently the University of Lisbon (ISCTE). He is member of several (inter)national scientific committees, and co-edi-tor of Health Education, Preventive Medicine, Psychology & Health, and Tobacco Prevention & Cessation. He has pu-blished more than 450 peer reviewed papers.

Abstract:One of the main goals of public health research is to in-form health-related policies. Over the past decades, tobac-co control policies have been supported by robust evidence generated by research. However, decisions on tobacco control policies are not always taken based on available evidence. Other factors such as the population’s attitudes, tobacco industry lobbying and socioeconomic considera-tions may influence policy decisions. This talk will explore the role of research in supporting evidence-based tobacco control both in the past and within the current context in Europe and beyond.

Biography:Dr Filippos Filippidis is a Lecturer in Public Health at the School of Public Health, Imperial College London. He has a background in medicine and has earned an MPH from the Harvard School of Public Health, with a focus on Quanti-tative Methods. His current research is focused on the epi-demiology of tobacco and e-cigarette use, tobacco control policies in European countries, as well as the effects of re-cession on health and risk factors, such as smoking.

Abstract 19 - 15:25 - 15:45

Mr Stephen LequetHead of Institutional Relations, dNF (Les droits des Non-Fumeurs) - FranceTaxation and Illicit Trade Protocol, “Lethal weapons” against Tobacco Industry

Abstract:Tobacco taxation is the most effective way to reduce smoking prevalence. Without tax increase tobacco policy, the other measures of tobacco control are weakened. While the EU Directive of 2011 on tobacco taxation is being evaluated, it is important to recall issues of this tobacco control tool. Fur-thermore, it is urgent to dismantle some against-truths dealt out by tobacco industry, like the supposedly postponing consumption on an illegal market which would then expan-ding, negating the reduction of tobacco consumption. On this important topic, the WHO Illicit Trade Protocol intro-duces comprehensive set of measures ranging from control

supply chain, strengthening penalties and technical and le-gal cooperation. The EU ratification is essential.Biography:Member of the ENSP Board, Stephen Lequet represents DNF, a French NGO acting, for more than 40 years, on several areas of Tobacco control : Judicial Watch and Litigation; Education and Health Promotion; Communication ; Infor-mation and advocacy. In DNF, he is Responsible for Public Affairs, Lobbying and Legal expertise. Stephen Lequet is also Assistant Professor at Sciences Po Paris (Institute of Political Studies in Paris), where he teaches Constitutional Law, Po-litical Institutions, Civil Liberties. He was before Advisor to the French Minister of Social Affairs.

- 18 -

Abstract 23

Abstract 22 - 17:30 - 17:50

Prof. Esteve Fernándezdirector, WHo Collaborating Center for Tobacco Control, Catalan Institute of oncology - SpainThe TackSHS project - a collaborative H2020 project

Abstract 21 - 17:15 - 17:30

Profs. Silvia Evers and Hein de VriesProfessors, Maastricht University - NetherlandsEQUIPT: supporting European stakeholders to make decisions about investment in evidence-based tobacco control

Abstract:In this presentation, we aim to describe a study that intends to provide health care policy makers and wider stakehol-ders in several European countries with bespoke informa-tion about the economic and wider returns that investing in evidence-based tobacco control including smoking cessation agendas can generate. While doing so, we intend to ask two pertinent questions: to what extent economic evidence gene-rated in one context can be transferred to another, and how? In this project, we refer to the NICE Tobacco ROI (UK) tool as the economic evidence and aim to co-create similar tools in other EU countries by enabling appropriate local adaptations and test their relevance and applicability. The first phase of the research included a contextual analysis in which needs as-sessment and stakeholder engagement were key components. This was achieved by stakeholder surveys and desk reviews, supplemented by a quantitative ‘importance analysis’ based on the results of PSA (probabilistic sensitivity analysis) on the existing ROI tool to identify the variables that were most sen-sitive to the context in question. The outcomes of this phase provided sufficient leads to re-model the ROI tools in sample countries (Germany, Hungary, Spain and the Netherlands). A comparative analysis of the results from these four tools will provide policy recommendations to be extrapolated for

Abstract:TackSHS is a new research project funded by the Euro-pean Union’s Horizon 2020 Research and Innovation Programme. It aims to improve our understanding of se-cond-hand tobacco smoke and e-cigarette emissions and find ways of tackling the health burden caused by exposure to them. Within a fast changing environment, the project will try to elucidate the comprehensive impact that SHS and e-cigarette aerosols have on respiratory health of the European population and how health impacts vary accor-ding to socio-economic parameters with particular empha-sis on specific vulnerable groups such as patients suffering from chronic lung diseases.Biography:Esteve Fernández, MD, MPH, PhD, is the Director of the WHO Collaborating Center at the Catalan Institute of

wider EU countries, especially the central and eastern Euro-pean region where the number of lives to be saved from to-bacco control interventions is much higher than the western European countries but little information exists as to how such programmes should be implemented. The final part of the presentation will focus on discussing a few challenges and inviting ideas to address them.Biography:Prof. dr. mr. Silvia Evers is a professor of Public Health Tech-nology Assessment at the Maastricht University, department of Health Services Research. Next to that, she is working at the Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Centre of Economic Evaluation. At the Maastricht University, she is programme leader of the programme ‘Creating value-based health care’ and profile coordinator of the HTA-trace of the Health Sciences Research Master. Cur-rently, she has been the co-supervisor of more than 20 Ph.D. students and more than 100 Bachelor and Master students. She has co-authored up to 200 (peer-reviewed) publications (Google’s H-index 33). She is editor of the International Jour-nal of Integrated Care (see www.ijic.org), the Journal of Mental Health Policy and Economics, and associate editor of BMC Health Services Research.

Oncology and associate professor of public health at Uni-versity of Barcelona. His main areas of research include tobacco control, electronic cigarettes, and cancer epide-miology. His has been Principal or Associate Investigator, or advisor, in several research projects in tobacco control funded by SANCO and FP7, and by Spanish agencies. He has published 238 papers in peer0reviewed journals (htt-p://j.mp/PubMedEsteve) with an H-index of 33 (Web of Science). Dr. Fernández is a consultant on tobacco control for WHO (EURO region and TFI program), and the Spa-nish and Catalan governments. He actually serves as Pre-sident of the Spanish Society of Epidemiology and has been the editor-in-chief of Gaceta Sanitaria (the journal of the Spanish Society of Public Health). He is reviewer for To-bacco Control, Nicotine and Tobacco Research, the Lancet, and the British Medical Journal, among other journals.

- 19 -

Abstract 23 - 17:50 - 18:10

Prof. Panagiotis BehrakisPresident of Scientific committee of ENSP (Belgium), Member of the BoR, the American College of Chest Physicians (USA), director, Institute of Public Health, the American College of Greece (Greece) - Greece.ToB-G: Tobacco Cessation Guidelines for High risk Populations

Abstract 24 - 18:10 - 18:30

Prof. Anton KunstProfessor AMC, University of Amsterdam - NetherlandsSILNE-R (Horizon2020)

Abstract 25

Abstract:The TOB-G project is funded under the EU 3rd Health Pro-gramme which is the main instrument that the Commis-sion uses to implement the EU Health Strategy. The project started in June 2014 and will be completed in September 2017. The project consortium consists of 5 partners from 4 European countries (Belgium, Greece, Ireland and Ro-mania).The TOB-G project aims to develop and implement an in-novative and cost effective approach to prevent chronic diseases related to tobacco dependence by focusing on creating specialized tobacco cessation guidelines for po-pulations of high risk including adolescents, pregnant wo-men, adults with COPD, Cardiovascular disease and dia-betes. The specialized guidelines for high risks groups will be developed according to ENSP’s evidence based and good practices in tobacco cessation. The smoking cessation gui-delines contain strategies and recommendations designed to assist clinicians/ doctors in delivering and supporting effective treatments for tobacco use and dependence and will also be available within the context of an e-learning platform for European clinicians.

Abstract:SILNE-R aims to evaluate how tobacco control policies can be implemented in such a way as to maximally contribute to a reduction in youth smoking in Europe. Previous eva-luations basically assessed whether or not a policy was effective and cost-effective. Often, it remained unclear how some programs achieve these observed effects, or why others failed to do so. The black-box remained closed. SILNE-R aims to open it. For this, we will perform in-depth analyses of the imple-mentation and effectiveness of several policies in both Fin-land, Germany, Belgium, Netherlands, Ireland, Italy and Portugal. We will (a) have in-depth interviews with policy makers at national and local levels, school staff, and pu-pils, (b) carry out the second wave of an interview survey among more than 12,000 pupils, and (c) prepare program cost inventories and produce cost-effectiveness estimates. Based on the results, we develop and disseminate recom-mendations on how to implement strategies to prevent

Overall, the TOB-G project will enhance the overall Eu-ropean capacity in the treatment of tobacco dependence, through offering smoking cessation tools, appropriately assessed and fitted to the specific needs of high risk groups.Biography:Panagiotis K. Behrakis, MD, PhD (McGill), FCCP. He is an MD (Athens University) with two PhDs (McGill and Athens Universities) and three medical specialties (Inter-nal Medicine, Pulmonary Medicine and Critical Care Me-dicine). President of the ENSP Scientific Committee, he is a former Associate Professor of Respiratory Physiology at Athens University and former Adjunct Professor at Har-vard University. He is currently the Director of the George D Behrakis Research lab of the Hellenic Cancer Society and of the Institute of Public Health of the American College of Greece. Currently he is the PI of the EU funded project, TOB-G and is actively involved in a number of other pro-jects (EPACTT, TACK-SHS, HEART) including tenders to the Commission to support the articles of the Tobacco Pro-ducts Directive (EUREST, PRECISE, DIRECT). He is the Editor-in-Chief of the ENSP journal, Tobacco Prevention & Cessation.

youth smoking in local settings, with due attention for pro-gram costs and for inequalities in smoking.Biography:Anton Kunst is professor in Social Epidemiology at the Department of Public Health at AMC, University of Ams-terdam. He is specialised in the analysis of trends in popu-lation health in European countries, with special emphasis on the role of tobacco and alcohol consumption. His main areas of interests are with health inequalities (between so-cio-economic groups, ethnic groups and regions) and the impact of policies and program on population health. He has extensive experience with the use of quantitative and mixed methods to evaluate public policies. He has coordi-nated several European project in the field of health inequa-lities and smoking, including the FP7 funded SILNE project and its successor, the Horizon2020 funded SILNE-R. He is co-author to about 320 papers in international scientific journals, 80 of which on tobacco smoking.

- 20 -

Abstract 28

Abstract 27 - 9:30 - 9:55

dr Carlos A. Jimenez-RuizHead of Smoking Cessation Service, Smoking Cessation Service of Community of Madrid - SpainSmoking Cessation in CoPd patients

Abstract 26 - 9:00 - 9:30

Ms Katie KemperExecutive director, Global Bridges, Mayo Clinic - USAGlobal Bridges: building an international network for tobacco dependence treatment

Abstract 25 - 18:30 - 18:50

dr Constantine Vardavas, Md, RN, MPH, Phd, FCCPScientific Coordinator, ENSP - BelgiumEUREST PLUS - European Regulatory Science on Tobacco: Policy implementation to reduce lung di-seases - Proposal (Horizon2020)

Abstract:EUREST-PLUS, a thirteen –partner EU joint project, coor-dinated by ENSP (Coordinator: Constantine Vardavas), aims to monitor and evaluate the impact of the TPD at a EU level. The specific objectives of the project are:1. To evaluate the psychosocial and behavioural impact of TPD implementation and FCTC implementation, through the creation of a longitudinal cohort of adult smokers in 6 EU MS (Germany, Greece, Hungary, Poland, Romania, Spain) in a pre- vs. post- study design.2. To assess support for TPD implementation through se-condary dataset analyses of the 2015 Special Eurobarome-ter on Tobacco Survey (SETS), and through trend analyses on the merged datasets of the 2009, 2012 and2015 SETS datasets.3. To document changes in e-cigarette product parame-ters (technical design, labeling, packaging and chemical

Abstract:Global Bridges, hosted at Mayo Clinic, is the most diverse international network of healthcare professionals dedi-cated to tobacco dependence treatment. Global Bridges works with grantees and partners in all six WHO regions to educate healthcare providers on evidence-based treat-ment and advocate for effective tobacco policy. This session will describe accomplishments and lessons learned in the Global Bridges program over nearly six years, and oppor-tunities to better integrate cessation support into compre-hensive tobacco control.Biography:Katie Kemper, MBA, PMP has built and managed success-

Abstract:Tobacco smoking is the main cause of COPD. Smoking ces-sation is the only therapeutic measure that can cure COPD and prevent this disorder from its chronic progression. Smoking cessation in COPD patients is difficult because most of these patients have specific characteristics that prevent them to quit. Recently, an ERS Task Force has de-

composition) following implementation of Article 20 of the TPD.4. To enhance innovative joint research collaborations, through the pooling and comparisons across both other EU countries of the International Tobacco Control (ITC) Pro-ject, and other non-EU countries.Biography:Dr Vardavas is a recognized international expert on tobac-co control, with a specific focus on European tobacco re-gulatory science. A former Senior Research Scientist at the Center for Tobacco Control at the Harvard School of Public Health, he now is based in Europe and spearheads a subs-tantial number of European wide initiatives and projects to advance the science behind tobacco control and support the impact of the Tobacco Products Directive. He is the co-Editor-in-chief of the ISPTID journal, Tobacco Induced Di-seases.

ful and productive international teams in the for-profit and not-for-profit sectors, focusing on public health issues, particularly tobacco control. Currently Executive Director of Global Bridges Healthcare Alliance for Tobacco Depen-dence Treatment, at Mayo Clinic, Katie’s responsibilities in-clude coordination of technical support, network building, evaluation and dissemination for grant projects repre-senting all WHO regions. Katie has also worked with the Campaign for Tobacco-Free Kids in Washington, D.C. as part of the Bloomberg Initiative, and for GlaxoSmithKline Consumer Healthcare as Vice President of global smoking control. She enjoys travel, water sports, and martial arts.

veloped a Consensus Document that contains recommen-dations for helping COPD smokers to quit.Biography:Head of Smoking Cessation Service of Community of Ma-drid. Director of the Research Tobacco Programme of the Spanish Respiratory Society, SEPAR. Chair of the Tobacco Control Committee, European Respiratory Society (ERS).

dAY 2: Wednesday 6th April 2016 (Smoking Cessation Training)

- 21 -

Abstract 29

Abstract 29 - 10:45 - 12:15

dr Arusyak Harutyunyan, Md, MPHSenior researcher, American University of Armenia - ArmeniaSmoking cessation services in Armenia

Abstract 28 - 9:55 - 10:15

Prof. Takashi HaniokaProfessor, Fukuoka dental College - JapanA brief tobacco intervention program in dental settings for developing countries.

Abstract:Brief intervention of smoking cessation by health profes-sionals has been recommended worldwide. However, this practice has not been fully achieved in dental setting. The present study aimed to examine training course to pilot implementation of the WHO policy recommendations on integrating brief tobacco interventions into oral health program regarding smoking cessation for current smokers and to avoid exposure to secondhand smoke for non-smo-kers. We held a 1-day training course for dental professio-nals in Japan. The training course was organized based on the training package for primary care providers, which aims to assist countries in taking one of their first steps towards providing comprehensive tobacco dependence treatment to all tobacco users by integrating brief tobacco interventions (brief advice) into primary care. As a total, 55 oral professionals, 32 dentists and 23 dental hygienists

Abstract:Eastern Europe has the highest smoking rates in Europe, yet tobacco dependence treatments are virtually unavai-lable in many Eastern European countries. Smoking rate among the Armenian men is one of the highest in the Eu-ropean region (63%, 2010). Armenia was the first former soviet union country to accede to the WHO Framework Convention on Tobacco Control (FCTC) (2004); soon af-ter that it adopted a national tobacco control law to ban smoking in healthcare, education, culture facilities and public transport. The country also banned tobacco adver-tising on TV and radio (2002) and on billboards (2006) and introduced larger (30%) health warnings on cigarette packs (2006). One of the areas where Armenia’s progress is less than satisfactory is the implementation of the FCTC Article 14. Current situation of smoking cessation services

from 19 private clinics and one university hospital, comple-ted the training course.Biography:Position: 1981- Research Associate, Osaka University Fa-culty of Dentistry; 1990-1991 Invited Researcher, Institute for Biomedical Research, University of Texas at Austin;2000- Associate Professor, Osaka University Graduate School of Dentistry;2002- Professor, Department of Public Health Dentistry and Preventive Dentistry, Fukuoka Dental College; and2002- Director, Division of Public Health & Human Sciences, Fukuoka Dental College. Main Works: Oral and clinical epidemiology; Tobacco control and smoking cessa-tion intervention; Periodontal microcirculatory functions; and Evaluation of oral health care products.Governmental activity: 2015, Ministry of Health, Labour and Welfare and 2016, Ministry of Finance of Japan.

in Armenia will be presented based on the results of quali-tative research among primary healthcare physicians and pharmaceutical market research.Biography:Dr. Arusyak Harutyunyan is a Senior Researcher in the Center for Health Services Research and Development (CHSR), American University of Armenia. She has joined the CHSR in May 2008 and has mainly been involved in Tobacco Control projects and led multiple quantitative and qualitative studies. Dr. Harutyunyan is the graduate of the Johns Hopkins University Bloomberg School of Public Health Global Tobacco Control Certificate program (2012) and in 2015 she completed the Mayo Clinic Nicotine Depen-dence Center’s Tobacco Treatment Specialist Certification Training Program and received Mayo Clinic’s provisional Tobacco Treatment Specialist Certificate.

- 22 -

Abstract 29

dr George BakhturidzeChairman, Tobacco Control Alliance - GeorgiaTobacco control and cessation challenges in Georgia

Prof. Antgona TroforAssociate Professor Md, Phd, University of Medicine and Pharmacy «Gr.T.Popa» Iasi, Clinic of Pulmo-nary diseases Iasi - RomaniaTobacco control and cessation in Romania – a situation analysis

Abstract:Romanian expertise in tobacco control and cessation is relatively young, as it has effectively started in the early ‘90’s. Ever since, smoking prevalence in the general popu-lation has decreased from 36.1% (48% B/25%F) in 2000 to 26.7% (37.4% B/16.7% F) in 2012, but it is still high and needs further efforts from the Romanian tobacco control community especially to address vulnerable populations and to develop tailored smoking prevention and cessation programs. Romania has ratified FCTC in 21 May 2003 and has signed it in 25 June 2004 A very recent achievement we are all proud of consists of the new law to ban smoking in public places, applied from 17.March 2016, a much stron-ger law than the past one we had since 2002. However, the future challenges will be to implement and ensure respect of this new law, to avoid its future amendments which already arise at the horizon, but also to introduce new regulation about taxation, illegal cigarettes traffic and e-cigarettes brands. A good point is the national Stop Smoking program that is still running since 2007 in over 50 Romanian smoking cessation centers to almost fully reimburse costs of pharmacotherapy and counselling. The constant preoccupation for education and expertise deve-lopment inside the Romanian Society of Pulmonologists, in particular through its Tobaccology section established in 2007 is another plus of the Romanian tobacco control society, as well as its numerous alliances with other na-tional and international professionals. This was fructified

Abstract:Tobacco Control Alliance contacted the new government and requested that it fulfils its obligations under the WHO FCTC, ratified in December 2012. The Prime Minister res-ponded adequately, and the government adopted in De-cember 2013, its first tobacco control national Strategy and 2013-2018 action Plan. But since, nothing has really been progressed on tobacco control matters, except insuffi-cient tax increase in September 2013 and in January 2015 (by 0.07 cents). On the other hand, local tobacco manufacturers received around 1.5 million Euros support from the Central Budget in 2015, while the Government spent only 20 000 Euros for tobacco control activities in the same year. It included mo-nitoring on enforcement of current tobacco control law in 1 400 facilities, training of 300 primary healthcare doctors on short advises technique and training for enforcement bodies. Our group has prepared amendments to the laws on to-bacco control and Government returned drafts to the MoH

in various networks that have contributed to producing national smoking cessation guidelines, to creating many partnerships in tobacco control projects and in the newly successful anti-tobacco legislation.Biography:Antigona Trofor, a senior chest physician at the Clinic of Pulmonary Diseases Iasi Romania. Working in clinical research in the field of chronic respiratory diseases since 2000, past president of the Tobaccology section of the Ro-manian Society of Pulmonologists, past member of the “To-bacco Control Committee” and past secretary of the Group 6.3. “Tobacco, Smoking Control and Health Education” of the European Respiratory Society, coordinator of the Ro-manian Smoking Cessation Guideline of the Romanian Society of Pulmonologists. She is author of 7 books and monographs, author or co-author of over 120 publications, project leader or member in numerous international tobac-co control projects, coordinator of two national smoking cessation governmental programs and principal investi-gator in over 30 clinical studies in the field of respiratory diseases. Since 2000, she has involved in developing uni-versity curricula for undergraduates and postgraduates in the field of smoking cessation, teaching an optional course “Basics in smoking cessation” for the Dentistry students and a smoking cessation postgraduate module for young doctors at the University of Medicine and Pharmacy “ Gr.T.Popa” from Iasi, Romania.

in March 2015. We organized translation of European smoking cessation guideline through ENSP support. TFK began an advocacy project in December 2015 together with us.Biography:Dr George Bakhturidze is a medical doctor and lawyer by profession. He has a master degree and finished PhD course in Health Promotion at University of Bergen. He has more then 17 years of experience in advocacy, law making, lob-bying and is engaged in research on tobacco control and health promotion issues. He has been involved in the ne-gotiations of the WHO Framework Convention on Tobacco Control (FCTC) since 2000, sometimes as a governmental representative and sometimes as a representative of the Tobacco Control Alliance in Georgia, which is a member of the Framework Convention Alliance (FCA) and European Network for Tobacco and Smoking Prevention (ENSP).

- 23 -

Abstract 29

dr otto StoykaCity Health Center of Health department, Health care departmet of Kyiv - UkraineImprove the quality of brief intervention skills

Prof. Andrey deminPresident, Russian Public Health Association - RussiaTobacco control and cessation in Eastern Europe - a situation analysis: The Russian Perspective

Abstract:Studied the consulting skills of physicians about patients smoking and methods of improve the quality of brief in-tervention skills. Conclusion: After providing training for physicians, all activities of doctors Clinical Interventions for Tobacco Use and Dependence among patients signifi-cantly increases. Doctors were twice more likely to record patients’ smoking status in primary health care documents. The percentage of those who do not record patients’ ciga-rette smoking status dropped. Also the quality of brief in-tervention such as advice has increased: they are more spe-cific and contain more data about the methods and means of stopping smoking. Doctors began to treat smoking pre-vention more consciously and reported the usefulness and

Abstract:Russia ratified WHO FCTC on 3 June 2008. On December 22, 2008 Federal law «Technical regulations on tobacco products» was adopted, probably normalizing activities of tobacco companies in view of risks posed by the Conven-tion. Annual production capacity exceeds 700 billion ciga-rettes. According to GATS the highest prevalence of tobac-co use in 2009 was in Russia, 39.1% of adults (43.9 million) used tobacco, smoking prevalence of 60.2% among men and 21.7% among women. In 2015, the Ministry of Health reported a 17% decline in the number of smokers since the adoption of tobacco control legislation in 2013. The law in-troduced comprehensive smoke free policies, picture war-nings, banned point of sales materials (POSM), alas stan-dards and order of cessation care have not been approved yet. Taxes are low and are regulated within Eurasian Eco-nomic Union agreements with a risk of remaining low. Ar-ticle 5.3 implementation and signing of Protocol on Illicit

effectiveness of smoking cessation advice. The above indi-cates the effectiveness of efforts to improve the way doctors work in smoking prevention outpatient network.Biography:Dr Otto Stoyka is a Chief Doctor of the City Health Center of Kyiv’s Health care Department and a teacher of Social Medicine Department at the O.Bogomolec National Medi-cine University. Master Degree: The PhD in Public Health area. The thesis submitted for a Master Degree of Science Medicine. He trains doctors on smoking cessation advise and alcohol consumption for patients in Kyiv. His field of research is the teaching of medical issues and evaluation of intervention of healthy environment.

Trade are among priorities.Biography:Andrei Demin, MD, Doctor of Political Sciences, Candi-date of Medical Sciences, MPH, Professor, Higher School of Health Administration under I.M. Sechenov First Mos-cow State Medical University, President of Russian Public Health Association. Work in leading academic, research, civil service (including Administration of President of Russia) and civil society organizations focused on public health, social security, health and health care policy and politics in international perspective, global health, public health interests advocacy, civil society involvement. State Duma expert. Co-authored projects, books, and policy reports: Participates in international collaboration, in-cluding FCTC. Fulbright fellow, 2001. Visiting scholar at GWU, 2001, LSHTM, 2006. WHO temporary adviser.

- 24 -

Abstract 30

Global Bridges

Global Bridges, established in collaboration with Mayo Cli-nic and the American Cancer Society, is an international network of healthcare professionals and organizations de-dicated to advancing evidence-based tobacco dependence treatment and effective tobacco control policy. Since its inception in 2010, Global Bridges partners and grantees have created culturally-relevant training curricula based on established best practice and trained more than 3600 healthcare professionals from 62 countries. Our multilin-gual website, globalbridges.org helps facilitate collabora-tion worldwide. Global Bridges, in partnership with Pfizer Independent Grants for Learning and Change, is proud to congratulate our European grantees on making a difference to health-care providers and their patients who want to stop using tobacco, through the following projects:

• American University of Armenia, “Implementing the FCTC Article 14 in Armenia through advocacy and trai-ning”• Catalan Institute of Oncology, “Development and dis-semination of a tobacco cessation training program for healthcare professionals in Spanish-speaking countries”• European Network for Smoking and Tobacco Prevention, “EPACTT – EuroPean Accreditation Curriculum on Tobac-co Treatment” • University of Arizona, “Building capacity for illness-spe-cific tobacco cessation among nurses and clinical psycholo-gists in Turkey”• University of Crete, “Developing a primary care tobacco dependence treatment network in Crete, Greece”

dr Krzysztof Przewozniakdeputy director WHo Collaborating Centre, Cancer Center and Institute - PolandTobacco control and cessation in Poland – a situation analysis

Abstract:In the 1980s, Poland was a country with extremely high prevalence of smoking and lung cancer mortality among men. The comprehensive tobacco control law and pro-grams initiated in the 1990s contributed to a spectacular decrease of smoking prevalence and smoking-attributable mortality in Poland. Since the beginning of 1990, domes-tic cigarette sales decreased from 100 to 45 billion of ciga-rettes. Between 1982 and 2015, prevalence of adult smoking declined in men from 65% to 28% and from 32% to 18% in women. The fall in smoking of manufactured cigarettes is also observed in youth population. The new challenges concern the rapid increase in smoking of hand-rolled ciga-rettes and in using of e-cigarettes, large discrepancies in smoking rates in educational and economic groups, rising proportion of heavy smokers and big percentage of women smoking menthol and slim cigarettes. The current tobacco control law proposal is aimed to stop these trends.

Biography:Krzysztof Przewozniak is a Sociologist of Medicine and Methodologist of Social and Life Sciences and has over 30 years experience in the field of public health, cancer and tobacco control. As public health and tobacco control ex-pert, he has been working or collaborating with the Wor-ld Health Organization, World Bank, Centers for Disease Control and Prevention, International Union Against Can-cer, International Agency for Research on Cancer, Johns Hopkins University, National Cancer Institutes in USA and Canada, US Environmental Protection Agency. He was project leader, principal investigator or collaborator in over 130 Polish and international research and interven-tion projects. He is author or co-author over 200 scienti-fic publications. For his scientific, social and public health work, he was awarded by President of the Republic of Po-land, Ministry of Health, Polish Academy of Sciences, UICC Globalink Network, and the Centers for Disease Control and Prevention in the United States.

- 25 -Abstract 32

Abstract 30 - 9:20 - 9:40

dr Kunnunen TaruBehavioral Scientist, ISPTId - USAWomen and Smoking: Global Challenge

Abstract:Global tobacco control has led to a reduction in smoking prevalence and mortality in men, while the rates among women have not followed the same declining rates or patterns. Tobacco-induced diseases, including those unique to women (reproductive complications, cervical and breast cancer) are becoming increasingly prevalent among wo-men. Unfortunately, many tobacco control policies and cessation programs have been found to be less effective for women than men. This is alarming as disease risk for lung cancer, CVD, osteoporosis, and COPD, associated with smoking, is higher among women. Women are also more likely to be exposed to secondhand tobacco smoke and sub-sequent morbidity. Finally, quitting smoking appears to be harder for women than men. Current tobacco control and surveillance data come primarily from high resource countries. WHO estimates that in 2030, in low and medium resource countries, 7 out of 10 deaths will be smoking-re-lated. While the prevalence of smoking in women is rela-tively low in these countries, more information is needed regarding their patterns of tobacco use uptake, and subse-quent health outcomes, as theirs differ from men. Tobacco use in women is greatly influenced by social, cultural and political determinants, and needs to be conceptualized wit-hin an intersectional framework.Krzysztof Przewozniak is a Sociologist of Medicine and Methodologist of Social and Life Sciences and has over 30 years experience in the field of public health, cancer and tobacco control. As public

health and tobacco control expert, he has been working or collaborating with the World Health Organization, World Bank, Centers for Disease Control and Prevention, Inter-national Union Against Cancer, International Agency for Research on Cancer, Johns Hopkins University, National Cancer Institutes in USA and Canada, US Environmental Protection Agency. He was project leader, principal inves-tigator or collaborator in over 130 Polish and international research and intervention projects. He is author or co-au-thor over 200 scientific publications. For his scientific, so-cial and public health work, he was awarded by President of the Republic of Poland, Ministry of Health, Polish Acade-my of Sciences, UICC Globalink Network, and the Centers for Disease Control and Prevention in the United States.Biography:Dr. Kinnunen received MA & PhD from the Department of Psychology at Northeastern University in Boston. She was tenure-track faculty at Harvard Medical School 1998-2014 and directed the Tobacco Dependence Treatment and Re-search Program at the Harvard School of Dental Medicine funded by NIH-NIDA. Currently she is the Chief Scientist at Behavioral Science Consulting and a Visiting Research Scientist at University of Helsinki, Finland. She has a strong commitment for teaching health care providers worldwide about prevention of tobacco and other addictions as well as applicable treatments and advancing behavioral and pre-ventive medicine globally, especially among underserved populations and women.

Abstract 31 - 10:00 - 10:20

Prof. J. Elliott ScottProfessor / Head of department, University of Manitoba and Manitoba Institute for Child Health - CanadaCaspase 3 activity in isolated fetal rat lung fibroblasts and rat periodontal ligament fibroblasts: ciga-rette smoke-induced alterations

Abstract:Background Cigarette smoking is the leading cause of preven-table death in the world. It has been implicated in the pathoge-nesis of pulmonary, oral and systemic diseases. Smoking du-ring pregnancy is clearly a risk factor for the developing fetus and may be a major cause of infant mortality. Moreover, the oral cavity is the first site of exposure to cigarette smoke and may be a possible source for the spread of toxins to other or-gans of the body. Fibroblasts in general are morphologically heterogeneous connective tissue cells with diverse functions. Apoptosis or programmed cell death is a crucial process du-ring embryogenesis and for the maintenance of homeostasis throughout life. Deregulation of apoptosis has been impli-cated in abnormal lung development in the fetus and disease progression in adults. Caspases, are proteases which belong

to the family of cysteine aspartic acid proteases and are the key components for the downstream amplification of in-tra-cellular apoptotic signals. Of the 14 caspases known, cas-pase-3 is the key executioner of apoptosis. Fetal rat lung fibroblasts but not PDL viability is reduced by exposure to CSE. In addition Caspase 3 activity is ele-vated after CSE exposure in fetal lung fibroblasts but not in PDLs.Expression of caspase 3 is induced in CSE exposed lung fibroblasts but not in PDLs. Caspase 3 was localized to the cytoplasm in both cell types.Biography:Currently, Professor and head of the Oral Biology depart-ment at the University of Manitoba, J. Elliott Scott’ research particularly focuses on lung development, toxicity of smoke and fungal toxins on lung cells.

day 3: Thursday, 7th April (Tobacco Induced diseases sponsored symposiums)

- 26 -

Abstract 34

Abstract 33 - 10:40 - 11:00

Prof. Nurcan Budunelidoctor, Ege University, School of dentistry, department of Periodontology - Turkeydifferentiation of chronic and aggressive forms of periodontitis and of smokers and non-smokers by Fourier-transform infrared spectroscopy

Abstract:Aim: To determine if Fourier-transform infrared spectros-copy (FTIR) could distinguish chronic periodontitis (CP) and aggressive periodontitis (AgP) patients by cross-sec-tional salivary spectral analyses and to assess the potential confounding influence of smoking on discriminating spec-tral signatures. Methods: FTIR analysis of saliva collected from patients with CP (n = 18, 7 smokers), AgP (n = 23, 9 smokers) was performed. Smoking status was confirmed by salivary cotinine analysis. Spectral band area analy-sis, hierarchical cluster analysis was performed. Results: Spectral analyses indicated significantly lower lipid, phos-pholipid, protein, amino acid, lactic acid, nucleic acid contents in smoker than non-smoker AgP group. Amino acid, phospholipid, lactic acid contents were significantly lower in smoker than non-smoker CP group. Thiocyanate levels successfully differentiated smokers from non-smo-kers, irrespective of periodontal status. Cluster analysis to

discriminate smokers from non-smokers and CP from AgP was highly promising. Conclusions: FTIR can be employed to discriminate smokers from non-smokers and CP from AgP.Biography:Dr.Buduneli has graduated from Ege University, Dental School in 1990, defended her PhD in 1996. Currently wor-king as a periodontist and professor at the Department of Periodontology, School of Dentistry, Ege University, Izmir, Turkey. Published more than 90 articles in well-known in-ternational scientific journals. Her main fields of interest are; etiology and pathogenesis of periodontal diseases, in-teractions of periodontal diseases and systemic diseases/conditions, novel diagnostic measures for periodontal di-seases. Dr.Buduneli is a member of various dental journals and also acts as an occasional referee in many other jour-nals. She is married and has a daughter and a son.

Abstract 32 - 10:20 - 10:40

dr david A. ScottProfessor, University of Louisville - USACigarette smoking and bacterial infectionAbstract:Smoking cigarettes and exposure to tobacco environmen-tal smoke increase the risk for many bacterial infections and / or exacerbates the symptoms of others. Many such infections can be life threatening. The underlying rea-sons for increased susceptibility are less clear. This talk will introduce examples of smoking-related bacterial di-seases; and the concepts of tobacco-augmented bacterial virulence; and immune system dysregulation that may decrease resistance to microbial infections.Fetal rat lung fibroblasts but not PDL viability is reduced by exposure to CSE. In addition Caspase 3 activity is elevated after CSE exposure in fetal lung fibroblasts but not in PDLs.Expres-

sion of caspase 3 is induced in CSE exposed lung fibroblasts but not in PDLs. Caspase 3 was localized to the cytoplasm in both cell types.Biography:David Scott received his BSc in Microbiology and PhD in Microbiology from Heriot-Watt University, Edinburgh and McGill University, Canada, respectively. Dr. Scott is currently a Professor of Oral Immunology and Infectious Diseases at the University of Louisville School of dentistry. His research focuses on elucidation of mechanisms by which tobacco dysregulates the immune response to bacte-ria, with an emphaisis on smoke-induced or -exacerbated periodontal (gum) diseases.

- 27 - Abstract 37

Abstract:Numerous effective medications are available for tobacco dependence treatment, and clinicians should encourage their use by all patients attempting to quit smoking. Ac-cording to the FCTC Article 14 Guideline “Tobacco cessa-tion medications should be made available to tobacco users wanting to quit and where possible be provided free or at an affordable cost”. Online survey was conducted among 9 countries (Armenia, Bangladesh, Brazil, India, Jordan, Nigeria, Spain, Turkey, Vietnam) to determine availabi-lity, affordability, and prices of smoking cessation drugs in countries that are Global Bridges grantees and to make comparisons across them. Preliminary findings of the on-line survey will be summarized during the presentation.

Biography:Dr. Arusyak Harutyunyan is a Senior Researcher in the Center for Health Services Research and Development (CHSR), American University of Armenia. She has joined the CHSR in May 2008 and has mainly been involved in Tobacco Control projects and led multiple quantitative and qualitative studies. Dr. Harutyunyan is the graduate of the Johns Hopkins University Bloomberg School of Public Health Global Tobacco Control Certificate program (2012) and in 2015 she completed the Mayo Clinic Nicotine Depen-dence Center’s Tobacco Treatment Specialist Certification Training Program and received Mayo Clinic’s provisional Tobacco Treatment Specialist Certificate.

Abstract 36 - 11:45 - 12:00

dr Arusyak HarutyunyanSenior Researcher, CHSR - ArmeniaAvailability, Affordability, and Prices of Smoking Cessation Products in 9 Countries: Preliminary Fin-dings

Abstract:Cytisine is a generic partial agonist of nicotine receptors α4β2 that has been available in Eastern Europe since 1960s. Through decades of observations and clinical studies, with much research conducted in Poland, cytisine has been shown to be safe and highly cost-effective medication in treatment for tobacco dependence, with a profile potentially more fa-vourable than that of varenicline. Poland remains among few European countries allowing for sales of cytisine. Cur-rently, cytisne-based treatment is available over-the coun-ter in Poland, where it is the dominant form of cessation pharmacotherapy. This presentation will outline the current state of knowledge on cytisine, as well as discuss the obser-vations on sales and use of cytisine in treatment of smoking cessation in Poland. A case will be made for cytisine emer-

ging as an ‘aspirin’ in smoking cessation, and an important element of future tobacco control worldwide.Biography:Aleksandra Herbec, MSc MA (Hons), is a Consultant and Researcher at Health Promotion Foundation in Poland led by Prof Witold Ztoński, and a British Heart Foundation PhD Candidate at the Department of Epidemiology and Public Health, University College London. Aleksandra is a psycho-logist specialising in behaviour change, eHealth, applied health psychology, and wider tobacco control, with focus on smoking cessation and adherence to stop smoking medica-tions. Since 2011 she has been working on developing and evaluating a range of digital programmes and tools suppor-ting smoking cessation and medication use.

Abstract 35 - 11:30 - 11:45

Aleksandra HerbećConsultant and Project Lead, Health Promotion Foundation - PolandCytisine in the treatment of tobacco dependence: safety, efficacy, market in Eastern Europe.

Abstract:This paper presents the picture of lung cancer mortality among women in the European Union in relation to patterns and trends in women smoking as a rising public health pro-blem. Based on WHO mortality statistics and international data on smoking prevalence, this analysis shows that lung cancer mortality among European women has been increa-sing for many years, and in the most of countries is already or will be in the next decade the leading cause of cancer deaths. The increase in lung cancer mortality is caused by a persistent epidemic of tobacco smoking in women and strongly associated with age patterns of smoking behaviors. Polish data also show on the consistency of lung cancer epidemic in men and women population, although there is a time lag in this epidemic in female population. Smoking

prevention and cessation should remain a priority of cancer primary prevention and health promotion in women.Biography:Professor Witold Zatonski has been at the front of public health and tobacco control in Poland, Eastern Europe, and internationally for over 40 years. He published over 500 pu-blications. He is a “father” of the Polish Tobacco Control, one of the most innovative tobacco control measures worldwide in the 1990s. He has been also instrumental in launching numerous public health campaigns in Poland, including Smoke-out and the European Code Against Cancer. For his distinguished career, he was awarded by WHO, American Cancer Society, President of the Republic of Poland and many other institutions and universities.

Abstract 34 - 11:00 - 11:15

Prof. Witold ZatonskiPresident, Health Promotion Foundation - PolandLung cancer and smoking among women – a new challenge in Europe

- 28 -

Abstract 38 - 12:15 - 12:30

Mr Joseph oSMANPresident, oFT Conseil - FranceHelping people stop smoking in workplaces: an alternative path

Abstract 39

Abstract:About 16 000 000 people are smoking in France. Those who have decided volontarily to stop, or those who need to stop for medical reasons are looking for help in some 800 smoking cessation medical centres. They represent a tiny part of the active smokers. An alternative way to reach and help the other smokers who do not want to stop or do not even consider stopping is to follow them through specific programs in their work-places.Initiated by Pr. Bertrand Dautzenberg 10 years ago «OFT» and then «OFT Conseil» have been developping different plans to address those smokers where they are working and encourager them to stop. The fact is that many medium and large size companies want their staffs to stop smoking to keep people in good health, to protect the image of the company or for any other reason. We are generally commissioned by the work doctors or by the human ressources managers to interve-ne. Each year OFT tobaccologists are working in some 75 to 100 companies. OFT and later OFT Conseil have developped a 3 steps pro-

gram especially addressed to the workplaces. The 3 steps are complementary although not mandatory: 1. confe-rence to smokers to raise awareness of well-being after stopping 2. Individual interview to pose a diagnostic and build up an individual cessation program 3. a smoking ces-sation protocol based on 6 to 10 consultation left over 6 to 8 months This plan is financed by the companies and followed only by graduated tobaccologists (faculty of medicine). The success rate in average is more or less 50 % to 60 % in the best cases (smokers who follow regularly and totally the program).Biography:- Master in Business Administration (ESSEC 1969 - France) - Graduate in Tovbaccology (Faculty of Medicine Paris 11 - 2007) - Graduate in Sociology (Sorbonne 1968) - Managing Di-rector of OFT (President: Pr. Bertrand Dautzenberg) from 2006 to 2015 - President of OFT Conseil, since 2015 - Managing Director of several French, German or and American technical books publishers from 1986 to 2005

Abstract 37 - 12:00 - 12:15

Mrs Charis GirvalakiPhd Candidate, Clinic of Social and Family Medicine, department of Medicine, University of Crete - GreeceTITAN Crete (Tobacco Treatment Training Network in Crete). designing Smoking Cessation interven-tion in Primary Care Practice: Preliminary data

Abstract:Aims and Objectives: We report on baseline tobacco treat-ment rates and changes in evidence-based tobacco treat-ment knowledge among General Practitioners (GPs), who participated in the TiTAN Crete training-based interven-tion. Methods: A pre-post control group evaluation was conduc-ted. GPs (n=15) completed a survey prior to and immedia-tely following the training session and a cross sectional patient sample of patients (n=540) was sampled pre-post intervention. Results: Tobacco use prevalence was 38%. The majority (64.1%) of tobacco users reported readiness to quit smoking in the next 6-months and 63.4% reported not having made a quit attempt in the past year. GPs tobacco treatment knowledge was limited at baseline. Significant increases in

knowledge were documented in 6/13 of the knowledge do-mains. A follow-up survey to examine changes in rates of tobacco treatment delivery among GPs is underway. Conclusions: The TiTAN Crete training program was ef-fective in increasing providers tobacco related knowledge.Biography:Charis Girvalaki is a chemist and has postgraduate MPH training in Public Health-Epidemiology. She is currently a doctoral trainee in the Clinic of Family Medicine at the Uni-versity of Crete. Her doctoral research will examine the use of the theory of planned behaviour in understanding out-comes related to the TiTAN Crete intervention program for smoking Cessation among primary care physicians. Her research interests are currently focused on the develop-ment, implementation and assessment of tobacco control initiatives and exposure to smoke.

- 29 -

Abstract 40 - 12:45 - 13:00

dr Matthew PhilpottExecutive director, European Healthy Stadia Network - UKTobaccofree Sports Stadia: European Policies and Guidance

Abstract 39 - 12:30 - 12:45

dr Barry A. FineganProfessor, University of Alberta - CanadaThe Hookah: Not Benign and Not Cultural

Abstract:Exposure to hookah has burgeoned among youth with ~ 40% responding to “ever used?” in a recent UK sample. Hookah use has been touted as safe especially if ‘herbal’ shisha is smoked and defended as a ‘cultural’ practice when banning hookah use in public spaces is proposed. Our data convincingly demonstrates that both these assertions are baseless. ‘Herbal’ shisha products tested contained toxic trace metals and PAHs levels equivalent to, or in excess of, that found in cigarettes. Their mainstream and sidestream smoke emissions contained carcinogens equivalent to, or in excess of, those of tobacco products. The content of the air in the waterpipe cafés tested where ‘herbal’ products were smoked contained potentially dangerous micro-particle and CO levels. Our qualitative research strongly suggests that peer influence, availability of flavoured products and

Abstract:Over 20 million people – including many children and young people - attend professional football matches across Europe each week, with many more attending other pro-fessional and amateur sports fixtures. The vast majority of European sports venues take place in semi-enclosed struc-tures with roofed stands, and yet there are still very low levels of smokefree and tobaccofree policies in operation. Building on research findings that only 10 out of UEFA’s 54 European countries have football stadia that operate to-baccofree policies, Healthy Stadia has worked with UEFA and World Heart Federation to develop new guidance ma-terials for clubs, multi-purpose stadium operators and go-verning bodies of sport to assist in the development and enforcement of strong tobacco control policies. This pre-sentation will give a benchmark of current policies in place, support offered through the new guidance materials, and advice on how sports organisations can go beyond natio-

facile access to hookahs in cafés are the major factors in initiation. Ethno-cultural issues play only a minor role.Biography:Dr. Finegan is a professor of anesthesiology in the Depart-ment of Anesthesiology and Pain Medicine at the Univer-sity of Alberta. He graduated from the National University of Ireland at Dublin, obtained his Fellowship in Anesthesia from the Royal College of Surgeons in Ireland, and subse-quently, the Royal College of Physicians in Canada. Over the last 12 years he has been leading hospital programs to reduce smoking rates in surgical patients, with the goal of promoting the long term reduction of cardiovascular/cancer risk. He research is focused on how to enhance com-munity cessation activities and counter emerging forms of smoking (hookah/e-cigarettes).

nal tobacco control legislation to implement tobaccofree policies.Biography:Matthew Philpott is Executive Director of European Healthy Stadia Network. He is responsible for the overall opera-tions and growth of Healthy Stadia, including partnership development, programme delivery and stakeholder re-lations. Matthew was programme manager for the EU funded European Healthy Stadia Programme (2007-10), and helped to establish Healthy Stadia’s partnership with World Heart Federation and UEFA. He has now worked on six EU funded programmes covering sport and health, and has contributed directly to the tobaccofree policy opera-ting at EURO 2012 and 2016. Matthew originally worked as a doctoral and post-doctoral researcher at University of Warwick (UK), gaining a PhD in Philosophy and Psycho-logy in 2001.

- 30 -

BoARd MEMBERSdr Pierre Bizel

Vice-president and Treasurer - ENSPBelgiumDr Pierre Gilbert Bizel is vice-president and treasurer of ENSP. He is spokesman of the Belgium Coalition against Tobacco and represents the Walloon Prevention Coalition. He is head of the Department «Healthy life style» at the Hainaut Health promotion Institute. For 15 years he has been a major player in the struggle against tobacco in francophone Belgium.

Ms Norma Cronin

Tobacco Control ConsultantASH Ireland - IrelandNorma Cronin is a Board member of ASH Ireland (Action on Smoking and Health). She is a Tobacco Control Consultant with a particular inte-rest in smoking cessation and training health care professionals. She is the former Cancer Prevention and Health Promotion Manager at the Iri-sh Cancer Society and had overall responsibility for tobacco control with more than 20 years experience in this area.In collaboration with the relevant agencies, she played a key role in en-suring the effective implementation of Ireland’s Smoke Free at Work le-gislation and has presented nationally and internationally on Ireland’s progressive tobacco control initiatives. Norma established and managed the National Smokers’ Quitline in Ireland. She is the former Chairperson of the Board of the Office of Tobacco Control (OTC), now the National Tobacco Control Office.Norma is also an Advisory Board Member of the International Network of Women against Tobacco (INWAT Europe).

Dr Niels Them Kjær

Head of Tobacco Controldanish Cancer Society - denmarkOriginally educated as chemist with a PhD in organic electrochemistry. Worked full time in tobacco control since 2000 as project manager in smoking cessation and later head of tobacco control at the Danish Cancer Society.Since 2013, member of the ENSP board.

Mr Stephen Lequet

Head of Institutional Relations,dNF (Les droits des Non-Fumeurs)FranceMember of the ENSP Board, Stephen Lequet represents DNF, a French NGO acting, for more than 40 years, on several areas of Tobacco control: Judicial Watch and Litigation; Education and Health Promotion; Com-munication; Information and advocacy.In DNF, he is Responsible for Public Affairs, Lobbying and Legal exper-tise. Stephen Lequet is also Assistant Professor at Sciences Po Paris (Ins-titute of Political Studies in Paris), where he teaches Constitutional Law, Political Institutions, Civil Liberties.He was before Advisor to the French Minister of Social Affairs.

Prof. Florin Mihălţan

President of the Romanian Networkfor Smoking PreventionInstitut of Pneumology “M.Nasta”RomaniaAuthor of over 500 papers published in Romanian Revue and Romanian journals, as well as 20 papers published in Revue de Maladie Respira-toire, Pneumologie, Chest etc., Prof Florin Mihaltan is interested and in-volved in studies about quitting smoking, home assistance of patients with chronic obstructive pulmonary disease, and in somnology.Author of many inquiries about smoking in Romania and studies on to-bacco control, prevalence of smoking in Romania, he has many roles in-cluding President of the Romanian Society of Pneumology, Vice-president of the association»Aer Pur» and President of the Romanian Network for Smoking Prevention.He has been a Board member for ENSP since April 2015.

dr Krzysztof Przewozniak

deputy director - WHo Collaborating Centre, Cancer Center and Institute - PolandKrzysztof Przewozniak is sociologist of medicine and methodologist of social and life sciences and has over 30 years experience in the field of public health, cancer and tobacco control. As public health and tobacco control expert, he has been working or collaborating with the World Health Organi-zation, World Bank, Centers for Disease Control and Prevention, International Union Against Cancer, International Agency for Research on Cancer, Johns Hopkins University, National Cancer Institutes in USA and Canada, US Environmental Protection Agency.He was project leader, principal investigator or collaborator in over 130 Polish and international research and intervention projects. He is author or co-author over 200 scientific publications.For his scientific, social and public health work, he was awarded by President of the Republic of Poland, Ministry of Health, Polish Academy of Sciences, UICC Globalink Network, and the Centers for Disease Control and Prevention in the United States.

dr Francisco Rodriguez Lozano

President - ENSP - SpainMedical Doctor, Univ. ZaragozaSpecialist in Dentistry, Univ. Complutense MadridMagister in Tobacco Control, Univ. CantabriaPresident of CNPT (National Committee on Tobacco Control), 2011- 2015PRESIDENT of ENSP (European Net for Smoking Prevention), 2015- nowadaysVicepresident of CED (Council of European Dentists), 2008-2011Board member of SEDET (Spanish Society of Tobacco Management and Control Specialists), 2007-10General Secretary of Spanish Dental Association, 2006-2010Associated professor in the Magister in Tobacco Dependence Management, Univ. of Cantabria and SevillaAuthor of different guides on smoking cessation for dentistry professionalsLobby work with Spanish parliamentarians, union representatives and jour-nalists for the latest Spanish Tobacco Law (2010) and its maintenance.Lobby work with Spanish MEPs for the latest Tobacco Products Directive (2014)

- 31 -

SECRETARIAT

SCIENTIFIC CoMMITTEE

Cornel Radu-Loghin

Secretary General - ENSP - BelgiumCornel Radu-Loghin is the Secretary General of the European Network for Smoking and Tobacco Prevention (ENSP), a position he has held since May 2015.Previously, he served as the ENSP Director of Policy and Strategy where he was responsible for coordinating and advocating the ENSP policies at the EU level, working in concert with European organizations involved in tobacco control and health promotion.Overall, Radu-Loghin has more than two decades of experience in tobacco control at national and international levels. He also served for three years as a board member for the Framework Convention Alliance (FCA) where he helped develop the organization’s 2013 strategic plan.

dominick Nguyen

Health Policy and CommunicationManager - ENSP - BelgiumWith over 15 years of experience in Public Health and more specifically in the field of Tobacco Control, Dominick has effectively managed a number of UK NHS stop smoking services, as well as running major national so-cial marketing campaigns.After a few years in Paris, working in the private sector in the fields of culture and education, he joined ENSP as the Health Policy and Commu-nication Manager in August 2015, and is responsible for the organisa-tion’s core activity and a number of work packages across a number of EU joint-projects. years as a board member for the Framework Convention Alliance (FCA) where he helped develop the organization’s 2013 strategic plan.

Andrea Glahn

Project Assistant - ENSP - BelgiumBefore joining ENSP Andrea has worked with EU funded projects in the fields of health and education at the Danish regional office to EU, ZealandDen-mark EU Office, and with public affairs and communications in the sector of medical technology at the Brussels based trade association MedTech Eu-rope. Andrea holds a Bachelor in Anthropology from the University of Copenhagen and a Master in European Studies with specific focus on European healthcare policy, from Université Libre de Bruxelles.A Danish national Andrea speaks fluently English and French and has a good command of German and Spanish. Andrea works more specifically with all the EU joint-projects, as well as taking part in the general activity of ENSP.

Prof. Panagiotis Behrakis

Panagiotis K. Behrakis, MD, PhD (McGill), FCCP, President of the ENSP Scientific Committee, is Associate Professor of Respiratory Physiology at Athens University and Adjunct Professor at Harvard University. He is an MD (Athens University) with two PhDs (McGill and Athens Universities) and three medical specialties (Internal Medicine, Pulmonary Medicine and Critical Care Medicine).He is currently the Scientific Director of the Smoking and Lung Cancer Research Centre and Investigator at the Biomedical Research Foundation of the Athens Academy. He is also President of the National Steering Committee for Tobacco Control and Principal Investigator of HEART Project (a colla-boration between Harvard University, the Hellenic Cancer Society and the Greek Ministries of Education and Health) for tobacco control in Greece, as well as chair of the Global Governors Council and member of the Board of the American College of Chest Physicians.In the past he has served as an auditor in a series major European projects (i.e. COPHIT, SIMBIO, BLOODSIM, BIOMED,AIM etc.), editor in eight scientific journals, editor and co-editor of seven books of physiology in Greece, supervisor of more than 30 PhD theses, author of 172 (89 international, 83 Greek) full papers and 350 (130 international, 220 Greek) abstracts accounting for 1420 citations.He has been the main organizer of more than 20 international scientific events (meetings, congresses, seminars) and has recently published a mono-graph The Greek Tobacco Epidemic, 2011, Harvard Publications.

Prof. Francisco Javier Ayesta, Md, PhdProfessor of Pharmacology & Addictive Disorders University of Cantabria, Santander, SpainDirector of the National Magister on Tobacco Dependence Management & Tobacco Control (1999-2015)President of SEDET (Spanish Society of Tobacco Specialists) (2007-2013).

Prof. Nazmi Bilir

MD. Professor of Public Health and Internal Medicine.Works at Hacettepe University Institute of Public Health, Ankara.Member of Advisory Committee of Ministry of Health.Member of Scientific Committee of Tobacco Regulatory Authority (TAPDK). Founder and past president of National Coalition on Tobacco Control (SSUK). Participated in Parliamentary discussions of Tobacco Control Law in 1996 and its amendment in 2008; actively involved in and wrote the report of Global Adult Tobacco Survey in 2008 and 2012.Performed several studies on implementation of Tobacco Control law, tobacco use behavior, graphic warnings, smoking cessation and has written several reports and books in this field.

- 32 -

oTHER CoNTRIBUToRS

Prof. Manfred Neuberger

M.D. 1971, certified internist 1977, public health & preventive medicine 1980, occupational medicine 1997. Deputy director of Vienna Municipal Institute of Environmental Medicine 1989-99. Full professor of environmental health at Medical University of Vienna 1999-2012. Consultant of WHO (IARC, IPCS, ECEH), UNDP, ILO, EC (DG research). Board member of societies of toxicology, pneumology, hygiene, occupational and environmental medicine. Member of scientific committees of several Austrian ministries and of the Commission on Climate & Air Quality of the Austrian Academy of Science. Member of scientific committee of ENSP and past president of www.aerzteinitiative.at. Published 471 papers and books, mainly on health effects of air pollution, cancer epidemiology and lung disease: http://www.meduniwien.ac.at/user/manfred.neuberger/daten/LIST.htm

Prof. Andrei demin

MD Doctor of Political Sciences, Candidate of Medical Sciences, MPH, Professor, Higher School of Health Administration under I.M. Sechenov First Moscow State Medical University, President of Russian Public Health Association.Work in leading academic, research, civil service (including Administration of President of Russia) and civil society organizations focused on public health, social security, health and health care policy and politics in international perspective, global health, public health interests advocacy, civil so-ciety involvement. State Duma expert. Co-authored projects, books, policy reports: Towards Healthy Russia.Focus on NCDs, 1993; THR. Prevention of NCDs in Context of Reforms, 1995; Political Problems of Social Security (Example of Health Care) in G7 countries, 2000; Preventive Approach to Public Health Issues, 2008; Tobacco Epidemic in Russia, 2009; Alcohol Use in the Russian Federation, 2009; European Smoking Cessation Guidelines and Quality Standards, 2012; Russian Tobacco Deal, 2012; Promoting Health of Migrants in Russia and U.S. through Social Changes, 2014. Participates in international collaboration, including FCTC.Fulbright fellow, 2001. Visiting scholar at GWU, 2001, LSHTM, 2006. WHO temporary adviser, 1994, 2008.

Prof. Bertrand dautzenberg

Professor in Chest Medecine in CHU Pitié-Salpêtrière hospital in Paris (Assistance Publique-Hôpitaux de Paris) and upmc Paris Sorbonne university.He is former president of Office Français de Prévention du Tabagisme (OFT), president of Paris sans Tabac (PST), Vice-president of Respadd (French hospital addiction network) and board member of French antitobacco alliance.He had head 2 experts conference on tobacco control (peri-operative and psychiatric patient), 2 reports for French government on passive smoking and e-cigarette. He heads the French AFNOR commission on e-liquid and e-cigarette (French normative organisation). He has written 14 books on tobacco.

Jorgen Falk

12 years experience from the school system, 17 years experience from the tobacco prevention field. Key-person in the area of information, documenta-tion, campaigning and media contact. Project manager on several tobacco prevention interventions in schools and key resource in developing Danish tobacco prevention policy at national level. Has worked as project manager for the Danish Smoking Cessation Campaign for several years and now as a Project Manager for National Centre for Smoking Cessation. Experience with EU programmes (Europe Against Cancer. Smoke-free Class Competi-tion, Quit and Win, Don’t Start and Win – Feel free to say no). In 2001 and 2002, has worked as Short Term Expert on a PHARE-TWINNING project concerning Smoking Prevention in Estonia (30 days). Has experience from tobacco policies and strategies in other EU countries during work in the three European projects and working groups.

Brian Ward

director of Advocacy and European Affairs, European Respiratory Society - Belgium

Before working at the ERS he was political adviser to Avril Doyle for three years during her term as a Member of the European Parliament. Brian began his work in Brussels in 2005 with an internship at the European Commission in the Cabinet of the Internal Market Commissioner, Charlie Mc Creevy. Prior to coming to Brussels he was a research assistant at the Institute of International and European Affairs, Dublin. He worked as a protocol officer at Government buildings in Dublin and he also served as a tutor of politics to students at University College Dublin.

Brian has a degree in German and a Masters in Politics and International studies from University College Dublin; he also studied European Union Law at King’s College London. He currently chairs the Institute of International and European Affairs, Brussels (IIEA) in a voluntary capacity.

Roberta Savli

Senior EU Policy Advisor & deputy director, EFA - Belgium

Roberta Savli works as a Deputy Director and Senior EU Policy Advisor at the European Federation of Allergy and Airways Diseases Patients’ Associa-tions (EFA) and is Treasurer of the Health and Environment Alliance (HEAL). Roberta represents EFA at the Policy Advisory Group of the European Patients’ Forum (EPF), the European Network for Smoking and Tobacco Prevention (ENSP), and the Patients’ and Consumers’ Working Party of the European Medicines Agency (EMA). Passionate about the environment and a committed tobacco control campaigner, before joining EFA, she worked at the European Commission and the European Parliament. Roberta Savli holds a double master degree in European Studies from the College of Europe.

Prof. Luke Clancy

BSc, M.B., M.D., PhD, F.R.C.P.I, F.R.C.P. (Edin), F.C.C.P., F.F.O.M.Director General of the TobaccoFree Research Institute Ireland (TFRI), Consultant Physician, St James Hospital.He led the support for the introduction of the Smokefree Workplace Legislation in 2004 when Ireland became the 1st country in the world to introduce smokefree bars and restaurants. He was ENSP and Chair of the ERS Tobacco Control Committee.He was President of the International Union against Tuberculosis and Lung Diseases (IUATLD), Chairman of the ERS TB Scientific Group and a TB Advisor to the WHO and Dept of Foreign Affairs Ireland.Current research includes e-cigarette usage in school students and plain packaging of tobacco, Horizon 2020 projects on Smoking in children, guide-lines for treatment of smoking cessation and measurement of health effects of SHS in exempted areas.

- 33 -

PRoJECTSToB.g

Tobacco Cessation Guidelines for High-risk populations Project

EQUIPT

European-study on Quantifying Utility of Investment in Protection from Tobacco

The TOB-G project is a three-year (June 2014 – September 2017) funded under the EU 3rd Health Programme which is the main instrument that the Commission uses to implement the EU Health Strategy. The project aims to develop and implement an innovative and cost effective approach to prevent chronic diseases related to to-bacco dependence by developing specialized tobacco cessation guidelines for populations of high risk. The specialized guidelines for high risks groups will be developed according to ENSP’s evi-dence based and good practices in tobacco cessation.The high-risk populations are people with: • Cardiovascular diseases• COPD• Type 2 diabetes• Adolescents • Pregnant women.

The project fits perfectly the objectives and priorities of the 3rd Health Programme, as it will assist health professionals to pro-vide guidance and targeted preventive activities to high risk populations that are tobacco dependent. It will enhance the ove-rall European capacity in the treatment of tobacco dependence,

The ultimate ambition of EQUIPT is to provide policy makers and wider stakeholders with bespoke information about the economic and wider returns that investing in evidence-based tobacco control – both smoking cessation and prevention agenda - can generate.By Sept 2016, EQUIPT will deliver a Tobacco Control Return on In-vestment (ROI) Tool - a web based economic model- that will allow European countries to estimate the ROI of tobacco control.

European policy makers can use the ROI tool to see whether their current tobacco control practice offers value for money. This tool will also allow them to see the extent to which they can improve on their current practice to provide better value for each Euro that they put in to their tobacco control agenda.

This type of information is very useful for policymakers in this time of austerity and can play a critical role in making the business case for tobacco control. EQUIPT has embraced a framework in which enormous efforts have been made to ensure that context-specific evidence on tobacco control (often originated from Western Europe) are transferable to other countries (e.g. Central and Eastern Europe). This will have enormous implications for saving lives as well as saving resources – both for health care and further research.

through offering smoking cessation tools, appropriately assessed and fitted to the specific needs of high risk groups.

The main project outcome is a set of smoking cessation guide-lines for each target group. The guidelines developed will contain strategies and recommendations designed to assist health pro-fessionals in delivering and supporting effective treatment of to-bacco dependence. Recommendations will be made as a result of scientific reviews and evidence of good practices from scientific groups that will consist of health professionals of different exper-tise in Europe.

Tob-G is a EU joint project, which include 5 partners from 4 coun-tries:ENSPThe Hellenic Center for Disease Control and PreventionThe Tobacco Free research Institute IrelandProoptiki LtdS.C. ANLET MED S.R.L

Further details on: http://tob-g.eu/

Based on the findings, we will develop and disseminate policy pro-posals as to which package of tobacco control interventions (i.e. an investment scenario) would provide the best value for money in the local setting. EQUIPT has included 15 interventions - covering pharmacothe-rapy, behavioural support and wider population-based strategies- to choose from to create an investment scenario.

Finally, EQUIPT will provide a comparative analysis, with an aim to inform the feasibility of harmonising Pan-European tobacco control strategies.

- 34 -

Tack SHS

Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interven-tions, impact on lung diseases and economic burden in diverse European populations.

Eurest Plus (proposal)

European Regulatory Science on Tobacco: Policy implementation to reduce lung diseases

TackSHS is a new research project funded by the European Union’s Horizon 2020 Research and Innovation Programme. TackSHS aims to improve our understanding of second-hand to-bacco smoke and e-cigarette emissions and find ways of tackling the health burden caused by exposure to them.

The project with a duration of 48 months (2 November 2015 – 1 November 2019) and a total budget of three Million Euros brings together leading European research centres, academic institutions and non-governmental organisations to work in partnership on a comprehensive and integrated approach to ge-nerate significant step-change beyond the current state-of-the-art in understanding second-hand tobacco smoke and electronic cigarette aerosols.

The multidisciplinary team of public health scientists, medical and environmental epidemiologists, occupational health specia-lists, respiratory physicians, health economists and policy experts will be working together within the project with the overall aim of characterizing the exposure of second-hand smoke in Europe and improving the understanding of the effects of second-hand tobac-co smoke and electronic cigarette aerosols on respiratory health. The project will also develop methods of measuring second-hand smoke and electronic cigarette aerosol in homes and cars, and will seek simple, low-cost approaches to help motivate smokers to make their homes smoke-free.Within a fast changing environment, this project will try to eluci-date the comprehensive impact that SHS and e-cigarette aerosols have on the European population and how health impacts vary according to socio-economic parameters with particular empha-sis on specific vulnerable groups such as patients suffering from chronic lung diseases.

Smoking and other forms of tobacco consumption are conside-red the single most important cause of preventable morbidity and premature mortality worldwide. Efforts to reduce the devasta-tion of tobacco-related deaths and illness in the EU consist of the Tobacco Products Directive (TPD), and the on-going implemen-tation of the WHO Framework Convention on Tobacco Control (FCTC). EUREST-PLUS, a thirteen –partner EU joint project, aims to mo-nitor and evaluate the impact of the implementing acts of the TPD and assess these within the context of FCTC ratification at an EU level. The 4 specific objectives of the project are:

1. To evaluate the psychosocial and behavioural impact of TPD implementation and FCTC implementation, through the creation of a longitudinal cohort of adult smokers in 6 EU MS (Germany, Greece, Hungary, Poland, Romania, Spain;) in a pre- vs. post-TPD study design. Moreover, these evaluation studies of the im-pact of the TPD and FCTC will be conducted with respect to vulne-rable populations.

Coordinated by the Institut Catala d’Oncologia (Spain), the TackSHS Project involves research institutes from six different European countries: • Agència de Salut Pública de Barcelona (Spain)• Istituto di Ricerche Farmacologiche “Mario Negri” (Italy)• The University of Aberdeen (United Kingdom)• TobaccoFree Research Institute Ireland LBG (Ireland)• Hellenic Cancer Society (Greece)• Fondazione IRCCS Istituto Nazionale dei Tumori (Italy)• Istituto per lo Studio e la Prevenzione Oncologica (Italy)• Universidad Politécnica de Cartagena (Spain)European Network for Smoking and Tobacco Prevention (Bel-gium)• Fundación para le Investigación Biomédica del Hospital Uni-versitario la Princesa (Spain)

For more information, visit: www.tackshs.eu

2. To assess support for TPD implementation through secondary dataset analyses of the 2015 Special Eurobarometer on Tobac-co Survey (SETS), a cross-sectional survey performed among 27,000 adults in all 28 EU MS, before the TPD is implemented and to monitor progress in FCTC implementation in the EU over the past years through trend analyses on the merged datasets of the 2009, 2012 and2015 SETS datasets.

3. To document changes in e-cigarette product parameters (tech-nical design, labelling, packaging and chemical composition) fol-lowing implementation of Article 20 of the TPD.

4. To enhance innovative joint research collaborations, through the pooling and comparisons across both other EU countries of the International Tobacco Control (ITC) Project, and other non-EU countries.

Overall, tackling tobacco use is quintessential to reducing the im-pact of chronic NCDs, a topic which we wish to address through EUREST-PLUS

- 35 -

dELEGATE LIST

SILNE-R

Tackling socio-economic inequalities in smoking: learning from natural experiments by time trend analyses and cross-national comparisons

The ambition of SILNE-R is to learn, by in-depth comparisons of seven European cities, how policies and programs to prevent youth smoking could enhance their effectiveness by taking into account the opportunities, barriers and resources present at local levels.

We expect to generate the fine-grained evidence that is needed to support decision makers in implementing smoking preven-tion strategies that are responsive to local conditions, effective in using available resources, and inspired to reduce inequities.

We will perform literature reviews using “realist” methodologies in order to assess what can make policies and programs work in practice, and why policies succeed in some cases and fail in others.

Next, we will make mix-method studies of comparing Finland (Tampere), Ireland (Dublin), Germany (Hannover), The Nether-lands (Amersfoort), Belgium (Namur), Italy (Cassino) and Por-tugal (Coimbra). In these studies, we will assess how recent

strategies and programs to prevent youth smoking have been im-plemented at national, municipal and school levels, and how they have influenced smoking behaviour of 16 year old adolescents.

Based on the results, we develop and disseminate recommenda-tions on how to implement strategies to prevent youth smoking in local settings, with due attention for program costs and for ine-qualities in smoking.

The project focuses on policies and programs that should be de-veloped not only at national levels, but also at local levels such as municipalities and schools. These include:• bans on smoking at public places (such as bars and clubs), bans on sales to minors (including monitoring and sanctioning), • restrictions to point-of-sale advertising (especially around schools),• bans on smoking at school premises (by students, staff, and vi-sitors),• school curriculum and educational programs (including smoke-free class contests).

First name Surname Position CountryArmine Abrahamyan American University of Armenia (AUA) Armenia

Joshua Abrams Campaign for Tobacco-Free Kids United States

Thomas Agar University of Waterloo Canada

Kurt Aigner Austrian Council on Smoking and Health Austria

Anna Eva Ampelas European Commission Belgium

david Andghuladze Tobacco Control Alliance in Georgia Georgia

Sopio Andghuladze Tobacco Control Alliance in Georgia Georgia

Tatiana Andreeva AdIC-Ukraine Ukraine

Fonari Antonina Training Resource Center Moldova

Pavel Antonov Smoke Free Life Coalition Bulgaria

F. Javier Ayesta Fac. Medicine, Univ. Cantabria Spain

Nune Azizyan National Tuberculosis Center Armenia

George Bakhturidze Tobacco Control Alliance in Georgia Georgia

Nino Bakhturidze Tobacco Control Alliance in Georgia Georgia

Leszek Bartłomiejczyk AFCEA, private individual Poland

Nicolas Becuwe TNS opinion Belgium

Panagiotis Behrakis ENSP Greece

Thomas Beutler Association Suisse pour la prévention du tabagisme Switzerland

Pierre Gilbert Bizel Tabac Wallonie Prévention - Province Hainaut Belgium

Sergei Bogdanov State Budgetary Educational Institution “Ural State Medical Univer-sity”, Ekaterinburg

Russian Federation

Martin Brenner department of Prosthodontics Johann Wolfgang Goethe-University Germany

Nurcan Buduneli Ege University, School of dentistry, department of Periodontology Turkey

oleg Buzik Moscow Research and Practical Center on Addictions Russia

Francisco Camarelles Guillem CNPT Spain

Maria Alejandra Cardenas Peinado dNF France

- 36 -

First name Surname Position CountryAntonella Cardone Individual member Italy

Maria Sofia Cattaruzza Università Sapienza Roma Italy

Simon Chapman The University of Sydney Australia

Kei Long Cheung Maastricht University Netherlands

Ramona Cioboata Clinical Hospital of Infectious diseases and Pneumology,»Victor Babes» Craiova

Romania

Teodora Ciolompea National Centre for Health Promotion Romania

Luke Clancy Tobacco Free Research Institute Ireland Ireland

Nonguebzanga Maxime Compaore Norwegian Cancer Society / Framework Convention Alliance Norway

Concha Cortes Vizcaino Universidad de Valencia Spain

Emma Croghan North 51 UK

Norma Cronin ASH Ireland Ireland

Vera Luiza da Costa e Silva Convention Secretariat, WHo Framework Convention on Tobacco Control

Switzerland

Armine danielyan Yerevan State Medical University after Mkhitar heratsi Armenia

Bertrand dautzenbeg Paris France

Hein de Vries Maastricht University Netherlands

Michele delaunay French PARLIAMENT France

Andrei demin Russian Public Health Association Russia

Irina demina Russian Public Health Association Russia

Stephan dierckx HELB Belgium

Pascal diethelm oxyRomandie Switzerland

Patrick doorley ASH Ireland Ireland

Aurélie douny Private Belgium

Marius Eremia Aer Pur Romania Romania

Silvia Evers Maastricht University Netherlands

Marine Faure European Respiratory Society Belgium

Bruno Federico University of Cassino and Southern Lazio Italy

Esteve Fernándz WHo Collaborating Center for Tobacco Control, Cataln Institute of oncology

Spain

Filippos Filippidis Imperial College London United Kingdom

Barry A Finegan University of Alberta Canada

Ewa Florek department of Toxicology, Poznan University of Medical Sciences Poland

Geoffrey Fong University of Waterloo Canada

Anastasios (Tasos) Fotiou University Mental Health Research Institute, Athens University Medical School

Greece

Marcela Fu Catalan Institute of oncology Spain

Suzanne Gabriels Belgian Foundation against cancer Belgium

Marine Gambaryan National Research Centre for Preventive Medicine Russia

Lali Gamkrelidze Tobacco Control Alliance in Georgia Georgia

Masha Gavrailova Smoke Free Life Coalition Bulgaria

Cristina-Maria Gavrilescu University of Medicine and Pharmacy Iasi Romania Romania

Elodie Gerard HELB Belgium

Charis Girvalaki Biomedical Research Foundation (BRFAA) of the Academy of Athens Greece

Andrea Glahn ENSP Belgium

Manon Golinvaux Province de Hainaut (observatoire de la Santé) Belgium

Sophie Goudet TNS opinion Belgium

Christina Gratziou University of Athens Greece

Tamar Gugutishvili Office of Ombudsman of Georgia Georgia

Kakha Gvinianidze Tobacco Control Alliance in Georgia Georgia

Takashi Hanioka Fukuoka dental College Japan

Hitomi Hanioka Wife of Prof. Takashi Hanioka Japan

Masashi Hanioka Child of Prof Takashi Hanioka Japan

Theodor Haratau Romtens Foundation Romania

Arusyak Harutyunyan American University of Armenia Armenia

Sanne Heijndijk dutch Alliance for a Smokefree Society Netherlands

Aleksandra Herbec Health Promotion Foundation Poland

Sara C. Hitchman King’s College London United Kingdom

Jan Hoffmann European Commission Belgium

Armen Hovasapian Yerevan No. 8 polyclinic Armenia

Karin Hummel Maastricht University Netherlands

Carlos Jimenez-Ruiz European respiratory Society, ERS Spain

- 37 -

First name Surname Position CountryLuk Joossens foundation against cancer Belgium

Paraskevi A. Katsaounou Hellenic Thoracic Society Greece

Katherine Kemper Mayo Clinic United States

Sheila Keogan TFRI Ireland

Biljana Kilibarda Institute of Public Health of Serbia Serbia

Taru Kinnunen ISPTId United States

Niels Them Kjær danish Cancer Society denmark

Theo Klargaard ASSEMBLEE NATIoNALE France

Tatiana Klimenko Federal medical scientific center of psychiatry and narcology by V.P.Serbsky

Russian Federation

olga Knorre Campaign for Tobacco-Free Kids Russia

Ekaterine Kobakhidze Tobacco Control Alliance in Georgia Georgia

Christina Koumpli CMT Prooptiki Greece

Kostiantyn Krasovskyy Ukrainian Institute for strategic research of the Ministry of Health Ukraine

Stepan Krinitskiy Tatarstan Republican Narcology dispensary Russia

Mirte Kuipers Academic Medical Center - University of Amsterdam Netherlands

Katharina Kummer Peiry Convention Secretariat, WHo Framework Convention on Tobacco Control

Switzerland

Anton Kunst AMC, University of Amsterdam Netherlands

oleg Kutushev Moskovskij nauchno-prakticheskij centrj narcologii Russia

Yuliia Lebetko Charitable foundation «Terra Nova» Ukraine

Stephen Lequet dNF France

Vladimir Levshin Russian Cancer Research Center Russia

Vladimir Levshin Russian Cancer Research Center Russia

Mads Schiøler Lind danish Health Authority denmark

Lucia Maria Lotrean University of Medicine and Pharmacy, Cluj-Napoca, Romania Romania

Neza Lovse Slovenian Coalition for Public Health, Environment and Tobacco Control

Slovenia

Miha Lovše Slovenian Coalition for Tobacco Control (SCTC) Slovenia

Viktoriia Madianova Sechenov First Moscow State Medical University Russia

Giorgi Maghradze Tobacco Control Alliance in Georgia Georgia

Milena Adina Man University of Medicine and Pharmacy Iuliu Hatieganu Romania

Tatevik Manukyan Gyumri MC Armenia

Monica Marc Hospital of Infectious diseases and Pneumology «Victor Babes» Timi-soara

Romania

Corina Marginean County Hospital Mures Romania

Truchet Marie Pfizer France

Anastasios Mastrogiannakis CMT PRooPTIKI Greece

Victoria Mendieta HELB Belgium

Florin dumitru Mihaltan Romanian Society of Pneumology Romania

Mariam Minasyan Nork Marash Medical Center Armenia

Ramona Miron Clinic of Pulmonary diseeases Iasi Romania

Ute Mons German Cancer Research Center (dKFZ) Germany

Narine Movsisyan Private/individual Armenia

Mette Gry Münchow danish Cancer Society denmark

Ioana Munteanu Marius Nasta Institute of Pneumology Bucharest Romania

oksana Naduta-Skrynnyk All Ukrainian NGo «Ukrainian Association of Family Medicine» Ukraine

Shirley Nelson department of Prosthodontics Johann Wolfgang Goethe-University Germany

dominick Nguyen ENSP Belgium

Paulien Nuyts Academic Medical Center Amsterdam Netherlands

Liliia Olefir Advocacy Center LIFE Ukraine

Joseph osman oFT conseil France

Susanna Palkonen EFA Belgium

Lambros Papadias European ombudsman Belgium

Zhanna Papoyan 17th Policlinic of Yerevan Armenia

Nana Peikrishvili Tobacco Control Alliance in Georgia Georgia

Nino Peikrishvili Tobacco Control Alliance in Georgia Georgia

Theodosia Peleki ENSP Greece

Jan Peloza No Excuse Slovenia/ Alcohol Policy Youth Network Slovenia

Ioanna Theodora Petroulia Center for Health Services Research, UoA Greece

Matthew Philpott European Healthy Stadia Network United Kingdom

Sophie Pierard SEPT asbl Belgium

- 38 -

First name Surname Position CountryNataliia Piven Ministry of Health Ukraine

Christine Plets Tabakstop - Foundation against cancer Belgium

Martina Poetschke-Langer German Cancer Research Center Germany

Aureliana Popa Asociatia Tinerii Uniti Romania

Ekaterine Popkhadze Office of Ombudsman of Georgia Georgia

Guido Poppelier Belgian Foundation against Cancer Belgium

Krzysztof Przewozniak Foundation «Smart Health - Health in 3d» Poland

Anne Quah UNIVERSITY oF WATERLoo Canada

Cornel Radu Loghin ENSP Belgium

Cris Rajo WHo Collaborating Center for Tobacco Control, Catalan Institute of oncology Spain

Jurgita Ribinskaite-Glatzer Lithuanian tobacco and alcohol control coalition Lithuania

Francisco Rodríguez Lozano ENSP Spain

Vladan Rovcanin private Montenegro/Norway

Kateryna Rymarenko NGo Advocacy Center Life Ukraine

Gohar Sahakyan Gyumri Policlinica NR 2 Armenia

Ioanna Sakellaraki Smoke Free Partnership Belgium

Roberta Savli EFA Belgium

Michael Schreuders Academic Medical Centre, Amsterdam Netherlands

david A. Scott School of dentistry - University of Louisville United States

J. Elliott Scott University of Winnipeg Canada

Liam Patrick Scott ISPTId United States

Sean Paul Scott ISPTId United States

Wahyu Septiono Academic Medical Centrum, University of Amsterdam Netherlands

Guzel Shakirova Cabinet of Ministers of the Republic of Tatarstan Russian Federation

Anna Shapoval Ukkrainian Center of Family Medicine Ukraine

Andrii Skipalskyi Advocacy Center «LIFE» Ukraine

Mariia Smirnova Research Institute of Phthisiopulmonology, Russian Quitline Russia

Shkumbin Spahija Kosovo Advocacy and development Centre Kosovo

olga Speranskaia Federal State Budgetary Institution “Federal Medical Research Center of Psyciatry and Narcology n.a.V.P.Speranskyi” of the Minis

Russia

Kristina Stoyanova Smoke Free Partnership Belgium

otto Stoyka City Health Center in Kyiv Ukraine

Tibor Szilagyi Convention Secretariat, WHo Framework Convention on Tobacco Control

Switzerland

Ingrid Talu Teachers agains Tobacco Sweden

Lucienne Thommes FoNdATIoN CANCER Luxembourg

Anca Toma Friedlaender Smoke Free Partnership Belgium

Ioana Roxana Tomus Asociatia Tinerii Uniti Romania

Enn Toom NGo Tobacco-free Estonia Estonia

Ioannis Tountas Center for Health Services Research Greece

Antigona Carmen Trofor University of Medicine and Pharmacy «Gr.T.Popa»Iasi, Romania Romania

Letitia Trofor Institute of Psychiatry «Socola» Iasi Romania

Aristeidis Tsatsakis University of Crete Greece

Tamila Tsirekidze Tobacco Control Alliance in Georgia Georgia

Aristeidis Ttsakis UNIVERSITY oF CRETE Greece

Kakha Vacharadze Tobacco Control Alliance in Georgia Georgia

Floor van den Brand Maastricht University Netherlands

dirk Jan van Mourik Maastricht University Netherlands

Katrijn Vandamme Vlaams Instituut voor Gezondheidspromotie en Ziektepreventie Belgium

dries Vandenbempt VIGeZ Belgium

Constantine Vardavas Biomedical Research, Foundation of the Academy of Athens (Greece) and ENSP (Belgium)

Greece

Victoria Vivilaki Midwifery department, TEI Athens Greece

Tomáš Vlach The Office of the Government of the Czech Republic - The Government Council for drug Policy Coordination

Czech Republic

olga Vysotska Ukrainian Family Medicine Training Center of Bogomolets National Medical University

Ukraine

Brian Ward European Respiratory Society Belgium

Marc Willemsen Maastricht university Netherlands

dmitry Yanin KoNFoP Russia

Witold Zatonski Health Promotion Foundation Poland

- 39 -

ENSP Conference on Tobacco Control: Research, Prevention and Treatment.

EVALUATIoN

Your Ideas Count!Evaluation Form

I would like to be kept informed and receive ENSP monthly e-newsletter

Suggestions for future events:

Email :

We appreciate hearing your com-ments, feedback and suggestions,which we will use for future eventplanning.After the event, you will receive a link to our online evaluation form. We would very much appreciate if you could take a few minutes to complete it.

However, you can complete it right away by going onto the fol-lowing link:

https://www.surveymonkey.co.uk/r/CH23WTd

or

by scanning the code below with your smartphone to complete the evaluation online:

European Networkfor Smoking and Tobacco Prevention aisbl

144 Chaussée d’IxellesB-1050 Brussels

Design : julienbourcet.fr